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July 31, 2002

Accompanying this letter is an exposure draft of a proposed Statement of Position (SOP),
Accounting and Reporting by Insurance Enterprises for Certain Nontraditional Long-Duration
Contracts and for Separate Accounts. A summary of the significant provisions of the proposed
SOP is included in the forepart of that document.
The purpose of the exposure draft is to solicit comments from preparers, auditors, and users of
financial statements and other interested parties. The Accounting Standards Executive
Committee (AcSEC) invites comments on all matters in the proposed SOP and particularly on the
following specific issues. Respondents need not comment on all of the issues and are
encouraged to comment on additional issues. Respondents should refer to specific paragraph
numbers and include reasons for any suggestions or comments.
Separate Account Presentation
Issue 1: The proposed SOP concludes that the portion of separate account assets representing
contract holder funds should be measured at fair value and reported in the insurance enterprise’s
financial statements as a summary total, with an equivalent summary total for related liabilities, if
the separate account arrangement meets all of the conditions specified in paragraph 10 of the
proposed SOP. If a separate account arrangement does not meet the criteria, the assets
representing contract holder funds under the arrangement should be accounted for as general
account assets, and any related liability also should be recognized with general account liabilities.
Do you agree that these are the appropriate criteria? Why or why not? If not, what criteria do you
propose?
Refer to paragraphs 9 through 11 and A1 through A9 of the proposed SOP.
Interest in the Separate Account
Issue 2: The proposed SOP concludes that assets underlying an insurance enterprise’s
proportionate interest in a separate account do not represent contract holder funds, and thus do
not qualify for separate account reporting and valuation. If a separate account arrangement
meets the criteria of paragraph 10 of the proposed SOP and (a) the terms of the contract allow for
the purchase of additional units in the separate account or (b) the insurance enterprise is
marketing contracts that permit funds to be invested in the separate account, the assets
underlying the insurance enterprise’s proportionate interest in the separate account should be
accounted for in a manner consistent with the accounting for similar assets held by the general
account that the insurance enterprise may be required to sell. Do you agree with this conclusion?
Why or why not? If not, what do you propose?
Refer to paragraphs 12 and 13 and A10 through A14 of the proposed SOP.
Gains on the Transfer of Assets from the General Account to a Separate Account
Issue 3(a): The proposed SOP concludes that assets transferred from the general account to a
separate account should be recognized at fair value to the extent of third-party contract holders’
proportionate beneficial interests in the separate account if the separate account arrangement
meets the criteria in paragraph 10 of this SOP. Any resulting gain related to the third-party
contract holder’s proportionate interest should be recognized immediately in earnings of the
general account of the insurance enterprise provided that the risks and rewards of ownership
have been transferred to contract holders. If the separate account arrangement does not meet
the criteria in paragraph 10 of this SOP, the transfer should have no financial reporting effect (that
is, general account classification and carrying amounts should be retained). Do you agree with
this conclusion? Why or why not? If not, what do you propose?
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Refer to paragraphs 14 and A15 of the proposed SOP.
Issue 3(b): The proposed SOP concludes that if the transferred asset is subsequently sold by the
separate account, any remaining unrecognized gain related to the insurance enterprise’s
proportionate beneficial interest should be recognized immediately in the earnings of the general
account of the insurance enterprise. If third-party contract holders’ proportionate beneficial
interests in the separate account are subsequently increased, or the insurance enterprise
otherwise reduces its proportionate interest in the separate account arrangement that meets the
criteria in paragraph 10 of the SOP, the reduction in the insurance enterprise’s proportionate
interest may result in additional gain. If an insurance enterprise’s proportionate interest
subsequently increases as a result of transactions executed at fair value (for example, at net
asset value), the increase is considered a purchase from the contract holder and should be
recognized at fair value. Do you agree with this conclusion? Why or why not? If not, what do you
propose?
Refer to paragraphs 15 and A15 of the proposed SOP.
Liability Valuation
Issue 4: The proposed SOP concludes that the basis for determining the balance that accrues to
the contract holder for a long-duration insurance or investment contract that is subject to Financial
Accounting Standards Board (FASB) Statement of Financial Accounting Standards No. 97,
Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for
Realized Gains and Losses from the Sale of Investments, is the accrued account balance as
described in FASB Statement No. 97, paragraphs 15 and 17(a). The accrued account balance
equals:
a.
b.
c.
d.
e.

Deposit(s) net of withdrawals;
Plus amounts credited pursuant to the contract;
Less fees and charges assessed;
Plus additional interest (for example, persistency bonus); and
Other adjustments (for example, appreciation or depreciation recognized in
accordance with paragraph 19 of the proposed SOP to the extent not already
credited and included in (b) above).

For contracts that have features that may result in more than one potential account balance, the
accrued account balance should be based on the highest contractually determinable balance that
will be available in cash or its equivalent. The accrued account balance should not reflect any
surrender adjustments (for example, market value annuity adjustments, surrender charges, or
credits). Do you agree with these conclusions? Why or why not? If not, what do you propose?
Refer to paragraphs 18, 20 through 21, and A16 through A19 of the proposed SOP.
Return Based on a Contractually Referenced Pool of Assets or Index
Issue 5: The proposed SOP concludes that for a contract not accounted for under the guidance of
FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities, that
provides a return based on the total return of a contractually referenced pool of assets (or a
contractually referenced interest rate index) either through crediting rates or termination
adjustments, the accrued account balance should be based on the fair value of the referenced
pool of assets (or applicable index value) at the balance sheet date even if the related assets are
not recognized at fair value. Do you agree? Why or why not? If not, what do you propose the
accrued account balance be based on?
Refer to paragraphs 19 and A20 of the proposed SOP.
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Annuitization Options
Issue 6: The proposed SOP discusses several alternative models, and for a variety of reasons
concludes that no liability should be established during the accumulation phase related to the
potential effect of annuitization options, even if the annuitization rates are favorable to the
contract holder. Do you agree? Why or why not? If not, what model or other alternative do you
propose?
Refer to paragraphs 22 and A21 through A30 of the proposed SOP.
Accounting for Contracts That Contain Death or Other Insurance Benefit Features
Issue 7(a): The proposed SOP concludes that for contracts classified as insurance contracts that
have amounts assessed against contract holders each period for the insurance benefit feature
that are not proportionate to the insurance coverage provided for the period, a liability should be
established in addition to the account balance to recognize the portion of such assessments that
compensate the insurance enterprise for benefits to be provided in future periods. Do you agree
with the conclusion to record an additional liability for amounts assessed that are not
proportionate to the insurance coverage provided for an insurance contract? Why or why not?
Issue 7(b): The proposed SOP also concludes that changes in this liability should be recognized
as a component of benefit expense. Do you agree with this conclusion? Why or why not? If not,
how do you propose the change in this liability be recognized?
Refer to paragraphs 26 and A35 through A41 of the proposed SOP.
Accounting for Contracts That Provide Only Death or Other Insurance Benefit Features
Issue 8: The proposed SOP concludes that an insurance enterprise, whether an issuer or
reinsurer, assuming only the insurance benefit feature of underlying noncancellable or
guaranteed renewable contracts that have been evaluated by the insurance enterprise to have
other than nominal mortality and morbidity risk, should calculate a liability for the portion of
premiums collected each period that compensates the insurance enterprise for benefits to be
provided in future periods, using the methodology as described in paragraphs 26 through 29 of
the proposed SOP. Do you agree the issuer of a death benefit wrap contract should calculate the
liability using the proposed methodology? Do you agree that a reinsurer should calculate the
liability also using the same methodology? Why or why not?
Refer to paragraphs 31 and A42 of the proposed SOP.
Sales Inducements to Contract Holders
The following two issues are related to the conclusions for sales inducements to contract holders:
Issue 9: The proposed SOP concludes that sales inducements provided to the contract holder,
whether for investment or universal life-type contracts, should be recognized as part of the liability
for policy benefits over the period for which the contract must remain in force for the contract
holder to qualify for the inducement or at the crediting date, if earlier, in accordance with
paragraph 18 of the proposed SOP. No adjustments should be made to reduce the liability related
to the sales inducements for anticipated surrender charges, persistency, or early withdrawal
contractual features. Do you agree with the conclusions relating to the recognition of a liability for
sales inducements? Why or why not?
Refer to paragraphs 32 and A18 through A19 of the proposed SOP.
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Issue 10: The proposed SOP concludes that sales inducements that are recognized as part of the
liability under paragraph 32 of the proposed SOP, that are explicitly identified in the contract at
inception, and that meet the criteria specified in paragraph 33 of the proposed SOP should be
deferred and amortized using the same methodology and assumptions used to amortize
capitalized acquisition costs. The insurance enterprise should demonstrate that such amounts are
(a) incremental to amounts credited on similar contracts without sales inducements; and (b)
higher than the contract’s expected ongoing crediting rates for periods after the inducement, as
applicable. That is, the crediting rate excluding the inducement should be consistent with
assumptions used in estimated gross profits or margins, contract illustrations, and interest
crediting strategies. The deferred amount should be recognized on the statement of financial
position as an asset, and amortization should be recognized as a component of benefit expense.
Do you agree with the criteria to qualify for sales inducement accounting, the financial statement
presentation, and the amortization methodology? Why or why not? If not, what accounting
treatments do you propose?
Refer to paragraphs 33 and A43 through A50 of the proposed SOP.
Disclosure
Issue 11: Do you agree that the disclosures required by the proposed SOP are useful for financial
statement presentation? If not, what disclosures would you propose?
Refer to paragraphs 34 through 35 of the proposed SOP.
Effective Date
Issue 12: The proposed SOP would be effective for financial statements for fiscal years beginning
after December 15, 2003, with early adoption encouraged. Assuming the issuance of a final SOP
during the second quarter of 2003, is the effective date appropriate?
Refer to paragraphs 36 and A51 of the proposed SOP.
Transition
Issue 13: The transition guidance outlined in paragraphs 37 through 39 of the proposed SOP is
complex. Do you agree that the transition guidance in the proposed SOP is appropriate? Why or
why not? If not, what transition guidance would you propose?
Refer to paragraphs 37 through 39 and A52 through A62 of this SOP.
Comments on the exposure draft should be sent by electronic mail to khekker@aicpa.org, or
addressed to Kim Hekker, Technical Manager, Accounting Standards, File 3162.LD, American
Institute of Certified Public Accountants, 1211 Avenue of the Americas, New York, NY
10036-8775, in time to be received by October 31, 2002. Responses should not be faxed.
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Written comments on the exposure draft will become part of the public record of the AICPA and
will be available for public inspection at the AICPA offices for one year after October 31, 2002.
Sincerely,

Mark V. Sever, CPA
Chair
Accounting Standards
Executive Committee

Thomas W. Walsh, CPA
Chair
Nontraditional Long-Duration
Contracts Task Force

Daniel J. Noll, CPA
Director
Accounting Standards
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SUMMARY
This Statement of Position (SOP) provides guidance on accounting and reporting by insurance
enterprises for certain nontraditional long-duration contracts and for separate accounts. This SOP
requires, among other things, the following:
•

Separate account presentation. This SOP concludes that the portion of separate account
assets representing contract holder funds should be measured at fair value and reported in
the insurance enterprise’s financial statements as a summary total, with an equivalent
summary total for related liabilities, if the separate account arrangement meets all of the
criteria specified in paragraph 10 of this SOP. If a separate account arrangement does not
meet the criteria, assets representing contract holder funds under the arrangement should be
accounted for and recognized as general account assets. Any related liability should be
accounted for as a general account liability.

•

Interest in separate accounts. This SOP concludes that assets underlying an insurance
enterprise’s proportionate interest in a separate account do not represent contract holder
funds, and thus do not qualify for separate account reporting and valuation. If a separate
account arrangement meets the criteria of paragraph 10 of this SOP and (a) the terms of the
contract allow the contract holder to invest in additional units in the separate account or (b)
the insurance enterprise is marketing contracts that permit funds to be invested in the
separate account, the assets underlying the insurance enterprise’s proportionate interest in
the separate account should be accounted for in a manner consistent with similar assets held
by the general account that the insurance enterprise may be required to sell.

•

Gains and losses on the transfer of assets from the general account to a separate account.
This SOP concludes that assets transferred from the general account to a separate account
should be recognized at fair value to the extent of third-party contract holders’ proportionate
beneficial interests in the separate account if the separate account arrangement meets the
criteria in paragraph 10 of this SOP. Any resulting gain related to the third-party contract
holder’s proportionate interest should be recognized immediately in earnings of the general
account of the insurance enterprise provided that the risks and rewards of ownership have
been transferred to contract holders. A guarantee of the asset’s value or minimum rate of
return or a commitment to repurchase the asset would not transfer the risks of ownership,
and no gain should be recognized. If the separate account arrangement does not meet the
criteria in paragraph 10 of this SOP, the transfer generally should have no financial reporting
effect (that is, general account classification and carrying amounts should be retained).
However, in certain situations loss recognition may be appropriate.
If the transferred asset is subsequently sold by the separate account, any remaining
unrecognized gain related to the insurance enterprise’s proportionate beneficial interest
should be recognized immediately in the earnings of the general account of the insurance
enterprise. If third-party contract holders’ proportionate beneficial interests in the separate
account are subsequently increased, or the insurance enterprise otherwise reduces its
proportionate interest in the separate account arrangement that meets the criteria in
paragraph 10 of this SOP, the reduction in the insurance enterprise’s proportionate interest
may result in additional gain. If an insurance enterprise’s proportionate interest subsequently
increases as a result of transactions executed at fair value (for example, at net asset value),
the increase is considered a purchase from the contract holder and should be recognized at
fair value.

•

Liability valuation. This SOP concludes that the basis for determining the balance that
accrues to the contract holder for a long-duration insurance or investment contract that is
subject to FASB Statement No. 97, Accounting and Reporting by Insurance Enterprises for
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Certain Long-Duration Contracts and for Realized Gains and Losses from the Sale of
Investments, is the accrued account balance as described in FASB Statement No. 97,
paragraphs 15 and 17a. The accrued account balance equals:
a. Deposit(s) net of withdrawals;
b. Plus amounts credited pursuant to the contract;
c. Less fees and charges assessed;
d. Plus additional interest (for example, persistency bonus); and
e. Other adjustments (for example, appreciation or depreciation recognized in
accordance with paragraph 19 of this SOP to the extent not already credited and
included in (b) above).
For contracts that have features that may result in more than one potential account balance,
the accrued account balance should be based on the highest contractually determinable
balance that will be available in cash or its equivalent without reduction for future fees and
charges expected to be assessed. The accrued account balance should not reflect any
surrender adjustments (for example, market value annuity adjustments, surrender charges, or
credits).
•

Return based on a contractually referenced pool of assets or index. This SOP concludes that
for a contract not accounted for under the guidance of FASB Statement No. 133, Accounting
for Derivative Instruments and Hedging Activities, that provides a return based on the total
return of a contractually referenced pool of assets (or a contractually referenced interest rate
index) either through crediting rates or termination adjustments, the accrued account balance
should be based on the fair value of the referenced pool of assets (or applicable index value)
at the balance sheet date even if the related assets are not recognized at fair value.

•

Annuitization options. This SOP concludes that no liability should be recognized during the
accumulation phase related to the potential effect of annuitization options.

•

Determining the significance of mortality and morbidity risk and classification of contracts that
contain death or other insurance benefit features. This SOP concludes that to determine the
accounting under FASB Statement No. 97 for a contract that contains death or other
insurance benefit features, the insurance enterprise should first determine whether the
contract is an investment or universal life-type contract. If the mortality and morbidity risks are
other than nominal and the fees assessed or insurance benefits are not fixed and
guaranteed, the contract should be classified as a FASB Statement No. 97 universal-life type
contract. The determination of significance should be made at contract inception, other than
at transition, and should be based on a comparison of the present value of expected excess
payments to be made under insurance benefit features with the present value of all amounts
assessed against the contract holder (revenue), under reasonably possible outcomes.

•

Accounting for contracts that contain death or other insurance benefit features. This SOP
concludes that for contracts classified as insurance contracts that have amounts assessed
against contract holders each period for the insurance benefit feature that are not
proportionate to the insurance coverage provided for the period, a liability should be
established in addition to the account balance to recognize the portion of such assessments
that compensates the insurance enterprise for benefits to be provided in future periods.
This SOP concludes that the amount of the additional liability, for an insurance benefit feature
that is included in a contract that is classified as an insurance contract and has amounts
assessed that are not proportionate to the insurance coverage provided for the period, should
be determined based on a ratio equal to the present value of total expected excess payments
and related expenses over the life of the contract divided by the present value of total
expected assessments over the life of the contract (benefit ratio). The liability at the balance
sheet date should be equal to:
a. The current benefit ratio multiplied by the cumulative assessments
10

b. Less the cumulative excess payments and related expenses
c. Plus accreted interest
However, in no event may the liability balance be less than zero. The change in the additional
liability should be recognized as a component of benefit expense in the statement of
operations.

•

Accounting for contracts that provide only death or other insurance benefit features. This
SOP concludes that an insurance enterprise assuming only the insurance benefit feature of
underlying contracts in a noncancellable or guaranteed renewable contract, or issuing a
contract that provides only an insurance benefit feature that wraps a noninsurance contract,
that has been evaluated by the insurance enterprise to have other than nominal mortality and
morbidity risk, should calculate a liability for the portion of premiums collected each period
that represents amounts to compensate the insurance enterprise for benefits to be provided
in future periods, using the methodology as described in paragraphs 26 through 30 of this
SOP.

•

Sales inducements to contract holders. This SOP concludes that sales inducements provided
to the contract holder, whether for investment or universal life-type contracts, should be
recognized as part of the liability for policy benefits over the period for which the contract
must remain in force for the contract holder to qualify for the inducement or at the crediting
date, if earlier, in accordance with paragraph 18 of this SOP. No adjustments should be made
to reduce the liability related to the sales inducements for anticipated surrender charges,
persistency, or early withdrawal contractual features.
This SOP also concludes that sales inducements that are recognized as part of the liability
under paragraph 32 of this SOP, that are explicitly identified in the contract at inception, and
that meet the criteria specified in paragraph 33 of this SOP should be deferred and amortized
using the same methodology and assumptions used to amortize capitalized acquisition costs.
The insurance enterprise should demonstrate that such amounts are (a) incremental to
amounts credited on similar contracts without sales inducements; and (b) higher than the
contract’s expected ongoing crediting rates for periods after the inducement, as applicable;
that is, the crediting rate excluding the inducement should be consistent with assumptions
used in estimated gross profits or margins, contract illustrations, and interest crediting
strategies. The deferred amount should be recognized on the statement of financial position
as an asset, and amortization should be recognized as a component of benefit expense.

•

Disclosures. This SOP requires certain disclosures related to the following:
a. Separate account assets and liabilities; the nature, extent, and timing of minimum
guarantees related to variable contracts and the insurance enterprise’s interest in
separate accounts (for example, seed money).
b. An insurance enterprise’s accounting policy for sales inducements, including the
nature of the costs capitalized and the method of amortizing those costs, the amount
of costs capitalized and amortized for each of the periods presented, and the
unamortized balance as of each balance sheet date presented.
c. The nature of the liabilities and methods and assumptions used in estimating any
contract benefits recognized in excess of the account balance pursuant to
paragraphs 17 and 32 of this SOP.

This SOP is effective for financial statements for fiscal years beginning after December 15, 2003,
with earlier adoption encouraged. This SOP may not be applied retroactively to prior years’
financial statements. Initial application of this SOP should be as of the beginning of an entity’s
fiscal year.
At the date of initial application of this SOP, an insurance enterprise will have to make various
determinations such as: qualification for separate account treatment, FASB Statement No. 115
11

classification of securities in separate account arrangements not meeting the criteria in paragraph
10 of this SOP, significance of mortality and morbidity risk, adjustments to contract holder
liabilities, and adjustments to estimated gross profits or margins,1 to determine the cumulative
effect of a change in accounting principle from adopting this SOP. Refer to paragraphs 37
through 39 of this SOP for specific transition guidance.

1

The term “estimated gross profits or margins” relates to estimated gross profits as defined in Financial
Accounting Standards Board (FASB) Statement of Financial Accounting Standards No. 97, Accounting and
Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and
Losses from the Sale of Investments, and estimated gross margins as defined in AICPA Statement of
Position 95-1, Accounting for Certain Insurance Activities of Mutual Life Insurance Enterprises, and will
hereinafter be referred to as estimated gross profits.
12
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FOREWORD
The accounting guidance contained in this document has been cleared by the Financial
Accounting Standards Board (FASB). The procedure for clearing accounting guidance in
documents issued by the Accounting Standards Executive Committee (AcSEC) involves the
FASB reviewing and discussing in public board meetings (1) a prospectus for a project to develop
a document, (2) a proposed exposure draft that has been approved by at least 10 of AcSEC’s 15
members, and (3) a proposed final document that has been approved by at least 10 of AcSEC’s
15 members. The document is cleared if at least four of the seven FASB members do not object
to AcSEC undertaking the project,* issuing the proposed exposure draft or, after considering the
input received by AcSEC as a result of the issuance of the exposure draft, issuing the final
document.
The criteria applied by the FASB in its review of proposed projects and proposed documents
include the following.
1.

2.
3.
4.

The proposal does not conflict with current or proposed accounting requirements, unless
it is a limited circumstance, usually in specialized industry accounting, and the proposal
adequately justifies the departure.
The proposal will result in an improvement in practice.
The AICPA demonstrates the need for the proposal.
The benefits of the proposal are expected to exceed the costs of applying it.

In many situations, prior to clearance, the FASB will propose suggestions, many of which are
included in the documents.

* At the time the Accounting Standards Executive Committee (AcSEC) undertook this project, at least five
of the seven Financial Accounting Standards Board members were required to not object to AcSEC
undertaking this project.
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PROPOSED STATEMENT OF POSITION
ACCOUNTING AND REPORTING BY INSURANCE ENTERPRISES FOR CERTAIN
NONTRADITIONAL LONG-DURATION CONTRACTS AND FOR SEPARATE
ACCOUNTS

INTRODUCTION AND BACKGROUND
Nontraditional Annuity and Life Insurance Contracts
1. At the time that Financial Accounting Standards Board (FASB) Statements of Financial
Accounting Standards No. 60, Accounting and Reporting by Insurance Enterprises, as amended,
and No. 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration
Contracts and for Realized Gains and Losses from the Sale of Investments, were issued, annuity
and life insurance contracts were generally one of two basic designs: fixed or variable. Traditional
fixed annuity and life insurance contracts, typically offered through an insurance enterprise's
general account,1 provide for a fixed rate of interest over some specified period, with the
insurance enterprise bearing the investment risk associated with the invested assets. Traditional
variable annuity and variable life insurance contracts, by contrast, offered through an insurance
enterprise’s separate account, provide that all investment risks associated with the separate
account assets are passed through to the contract holder, with no guarantees of return of
principal, minimum crediting rates, or, for annuity contracts, minimum death benefits.
2. More recently, annuity and life products with nontraditional terms have been developed.
Some of those products may combine fixed and variable features and are sold as general
account or separate account products. The features of nontraditional contracts are many and
complex, and may be offered in different combinations, such that there are numerous variations
of the same basic products being sold in the marketplace. See examples of products in Appendix
D of this Statement of Position (SOP).
Contract Features
3. A common feature in variable annuities is a minimum guaranteed death benefit (MGDB)
such as a death benefit equal to the total deposits made by the contract holder less any
withdrawals, referred to as “return of premium” or “basic” MGDB. Although the return of premium
MGDB has become increasingly common in variable annuities, the trend has been for insurers to
offer MGDBs with more extensive benefit guarantees, such as:
a. A death benefit equal to the total of deposits made to the contract less an adjustment
for partial withdrawals, accumulated at a specified interest rate, often referred to as
“roll up.”
b. A death benefit equal to the account balance on a specified anniversary date
adjusted for deposits less partial withdrawals since the specified anniversary date,
often referred to as “reset.”

1

Terms defined in the glossary are set in boldface type the first time they appear in this Statement of
Position (SOP).
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c.

A death benefit equal to the highest account balance among prior specified
anniversary dates adjusted for deposits less partial withdrawals since the specified
anniversary date, often referred to as “ratchet.”

4. Contracts also exist that potentially may be viewed as providing multiple account balances,
for example:
a. A fixed annuity that provides for the return of principal and interest if held until
maturity or a specified “market adjusted value” if surrendered at an earlier date.
b. An annuity that has multiple crediting rates throughout the life of the contract
depending on whether the contract holder elects to terminate or annuitize the
contract.
c. A variable annuity that provides a guaranteed minimum amount available to
annuitize after a specified period in addition to a guaranteed minimum annuity
interest rate.
5. Sales inducements to contract holders may be offered with fixed and variable life insurance
and annuity contracts. Those inducements may be offered in many forms, including an immediate
bonus, a persistency bonus credited to the contract holder’s account after a specified period, or
an enhanced crediting rate, or “bonus interest” rate, in the initial period(s) of the contract.
6. FASB Statement No. 97 provides no explicit accounting guidance for the above examples of
nontraditional contract features. This SOP addresses the insurance enterprise’s accounting for
certain contract features not covered by other authoritative accounting guidance, including asset,
liability, revenue, and expense recognition. Embedded derivatives contained in nontraditional
contracts should be accounted for in accordance with FASB Statement No. 133, Accounting for
Derivative Instruments and Hedging Activities, and its related guidance.2
7. In addition, this SOP addresses the insurance enterprise’s accounting for separate account
assets and liabilities related to contracts for which all or a portion of the investment risk is borne
by the insurer.
APPLICABILITY AND SCOPE

8. This SOP is applicable to all entities to which FASB Statement No. 60, as amended, applies,
hereinafter referred to as insurance enterprises.3

2

Refer to the Financial Accounting Standards Board’s (FASB’s) publication, Accounting for Derivative
Instruments and Hedging Activities, for the following insurance-specific FASB Derivative Implementation
Issues: B7-Variable Annuity Products and Policyholder Ownership of the Assets, B8-Identification of the
Host Contract in a Nontraditional Variable Annuity Contract, B9-Clearly and Closely Related Criteria for
Marked Adjusted Value Prepayment Options, B10-Equity-Indexed Life Insurance Contracts, B25-Deferred
Variable Annuity Contracts with Payment Alternatives at the End of the Accumulation Period, B29-EquityIndexed Annuity Contracts with Embedded Derivatives, B30-Application of Statement 97 and Statement
133 to Equity-Indexed Annuity Contracts and B34-Period Certain Plus Life-Contingent Variable Payout
Annuity Contracts with a Guaranteed Minimum Level of Periodic Payments.
3
FASB Statement No. 60, Accounting and Reporting by Insurance Enterprises, as amended, applies to life
insurance enterprises, property and liability insurance enterprises, title insurance enterprises, mortgage
guaranty insurance enterprises, assessment enterprises, and fraternal benefit societies.
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CONCLUSIONS
Separate Account Presentation
9. Separate account assets and liabilities should be included in the financial statements of the
insurance enterprise that owns the assets and is contractually obligated to pay the liabilities.
10. The portion of separate account assets representing contract holder funds should be
measured at fair value and reported in the insurance enterprise’s financial statements as a
summary total, with an equivalent summary total reported for related liabilities, if the separate
account arrangement meets all of the following conditions:
a. The separate account is legally recognized. That is, the separate account is
established, approved, and regulated under special rules such as state insurance
laws, federal securities laws, or similar foreign laws.
b. The separate account assets supporting the contract liabilities are legally insulated
from the general account liabilities of the insurance enterprise (that is, the contract
holder is not subject to insurer default risk to the extent of the assets held in the
separate account).
c. The insurer must, as a result of contractual, statutory, or regulatory requirements,
invest the contract holder’s funds within the separate account as directed by the
contract holder in designated investment alternatives or in accordance with specific
investment objectives or policies.
d. All investment performance, net of contract fees and assessments, must as a result
of contractual, statutory, or regulatory requirements be passed through to the
contract holder. Contracts may specify conditions under which there may be a
minimum guarantee, but not a ceiling, as a ceiling would prohibit all investment
performance from being passed through to the contract holder.
For the portion of separate account arrangements meeting the criteria above, the related
investment performance (including interest, dividends, realized capital gains and losses, and
changes in unrealized gains and losses) and the corresponding amounts credited to the contract
holder should be offset within the same statement of operations line item netting to zero. Contract
fees and assessments should be reported in accordance with FASB Statement No. 97, paragraph
19. Any liabilities related to minimum guarantees and insurance benefit liabilities under the
contracts in excess of the fair value of separate account assets representing contract holder
funds should be recognized as general account liabilities.
11. If a separate account arrangement does not meet the criteria in paragraph 10 of this SOP,
assets representing contract holder funds under the arrangement should be accounted for
(measured and presented) the same as other general account assets as prescribed in
paragraphs 45 through 51 of FASB Statement No. 60, as amended. Any related liability should be
accounted for as a general account liability. Revenue and expenses related to such arrangements
should be recognized within the respective revenue and expense lines in the statement of
operations. Arrangements in which contract holders’ funds are maintained in separate accounts
to fund fixed account options of variable contracts, market value adjusted contracts, guaranteed
investment contracts, and indexed contracts are examples of separate account arrangements that
would not meet the criteria in paragraph 10 because all of the investment performance on these
investments is not passed through to the contract holder.

Accounting for an Insurance Enterprise’s Interest in a Separate Account
12. Assets underlying an insurance enterprise’s proportionate interest in a separate account
(seed money or other investment as described in paragraph A10 of this SOP) do not represent
contract holder funds, and thus do not qualify for separate account accounting and reporting. The
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insurance enterprise should “look through” the separate account for purposes of accounting for its
interest therein, and account for and classify the assets underlying that interest based on their
nature as if the assets underlying the insurance enterprise’s proportionate interest were held
directly by the general account rather than through the separate account structure.4

13. If a separate account arrangement meets the criteria in paragraph 10 of this SOP, and (a) the
terms of the contract allow the contract holder to invest in additional units in the separate account
or (b) the insurance enterprise is marketing contracts that permit funds to be invested in the
separate account, the assets underlying the insurance enterprise’s proportionate interest in the
separate account should be accounted for in a manner consistent with the accounting for similar
assets held by the general account that the insurance enterprise may be required to sell. For
instance:
a. For a debt or equity security with an unrealized loss, the loss should be accounted
for as an other than temporary impairment under the guidance of FASB Statement
No. 115, Accounting for Certain Investments in Debt and Equity Securities, and
recognized in the statement of operations as a realized loss.
b. The guidance in FASB Statement No. 144, Accounting for the Impairment or
Disposal of Long-Lived Assets, should be followed for both real estate that is held for
sale and real estate that is not held-for-sale. For real estate that does not meet the
FASB Statement No. 144 held for sale criteria, the impairment test should be
performed using undiscounted future cash flows assuming the insurance enterprise’s
proportionate interest in the separate account will be immediately reduced to zero.

14. Assets transferred from the general account to a separate account should be recognized at
fair value to the extent of the third-party contract holders’ proportionate beneficial interests in the
separate account if the separate account arrangement meets the criteria in paragraph 10 of this
SOP. Any resulting gain related to the third-party contract holders’ proportionate beneficial
interest should be recognized immediately in earnings of the general account of the insurance
enterprise provided that the risks and rewards of ownership have been transferred to contract
holders. A guarantee of the asset’s value or minimum rate of return or a commitment to
repurchase the asset would not transfer the risks of ownership, and no gain should be
recognized.5 If the separate account arrangement does not meet the criteria in paragraph 10 of
this SOP, the transfer generally should have no financial reporting effect (that is, general account
classification and carrying amounts should be retained). Consistent with the guidance in footnote
8 of this SOP, the insurance enterprise should recognize an impairment loss on an asset
transferred from the general account to a separate account not meeting the criteria in paragraph
10 of this SOP if the terms of the arrangement with the contract holder are such that the
insurance enterprise will not be able to recover the asset’s carrying value. The insurance
enterprise should recognize an impairment loss on its proportionate interest in a separate account
arrangement meeting the criteria in paragraph 10 in a situation where the current fair value of the
insurance enterprise’s proportionate interest in the separate account assets is less than its
carrying amount.

15. If the transferred asset is subsequently sold by the separate account, any remaining
unrecognized gain related to the insurance enterprise’s proportionate beneficial interest should be
recognized immediately in the earnings of the general account of the insurance enterprise. If
third-party contract holders’ proportionate beneficial interests in the separate account are
subsequently increased, or the insurance enterprise otherwise reduces its proportionate interest
in the separate account arrangement that meets the criteria in paragraph 10 of this SOP, the
reduction in the insurance enterprise’s proportionate interest may result in additional gain. If an
insurance enterprise’s proportionate interest subsequently increases as a result of transactions

4

See example in Appendix B.
If the asset transferred is real estate, no gain can be recognized if recognition is inconsistent with FASB
Statement No. 66, Accounting for Sales of Real Estate.

5
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executed at fair value (for example, at net asset value), the increase is considered a purchase
from the contract holder and should be recognized at fair value.

16. For example, the general account transfers to the separate account arrangement, as seed
money, a debt security with a book value of $60 and a fair value of $100. No gain is recognized
on the initial transfer to the separate account arrangement. Contract holders direct $100 to the
separate account arrangement, reducing the general account’s proportionate interest to 50
percent. Assuming the fair value of the debt security is still $100, the general account recognizes
a gain of $20, as a result of the contract holder investment into the separate account
arrangement. In subsequent years, if the insurance enterprise reduces its interest in the separate
account arrangement through withdrawal of cash or additional investment by contract holders,
additional gains would be recognized if the fair value continues to exceed the general account’s
basis in the security.
Valuation of Liabilities

17. Paragraphs 18 through 22 of this SOP provide guidance for determining the balance that
accrues to the benefit of contract holders under paragraphs 15 and 17(a) of FASB Statement No.
97. Paragraphs 23 through 31 of this SOP provide guidance for determining any additional liability
for death or other insurance benefit features under paragraph 17(b) of FASB Statement No. 97.
Paragraph 32 of this SOP provides guidance for determining any additional liability for sales
inducements.

18. The balance that accrues to the benefit of the contract holder for a long-duration insurance or
investment contract that is subject to FASB Statement No. 97 (paragraphs 15 and 17(a)) is the
accrued account balance. The accrued account balance6 equals:
a. Deposit(s) net of withdrawals;
b. Plus amounts credited pursuant to the contract;
c. Less fees and charges assessed;
d. Plus additional interest (for example, persistency bonus); and
e. Other adjustments (for example, appreciation or depreciation recognized in accordance
with paragraph 19 of this SOP to the extent not already credited and included in (b)
above).
For purposes of item (d) above, additional interest is an amount that is required to be accrued
under the liability valuation model that has not yet been credited to the contract holder’s account.
Additional interest, if any, should be accrued through the balance sheet date at the rate that
would accrue to the balance available in cash, or its equivalent,7 before reduction for future fees
and charges, at the earlier of the date that the interest rate credited to the contract is reset or
contractual maturity. The reset date is the date at which the existing contractually declared
investment return expires.
19. Some contracts, such as variable life and annuity and certain group pension participating and
other experience-rated contracts, provide for a return through periodic crediting rates, surrender
adjustments, or termination adjustments based on the total return of a contractually referenced
pool of assets owned by the insurance enterprise. Insurance enterprises should determine
whether such contracts fall within the scope of FASB Statement No. 133. If the contract does not
fall within the scope of FASB Statement No. 133, the amount of other adjustments described in
paragraph 18 of this SOP should be based on the fair value of the referenced pool of assets at
the balance sheet date, even if the related assets are not recognized at fair value, to the extent
not already credited to the accrued account balance and included in paragraph 18(b) of this SOP.
6

A portion of the accrued account balance may be presented in separate account liabilities and general
account policyholder liabilities, as appropriate.
7
For this purpose, an asset or contract is the equivalent of cash if it has a readily determinable fair value
and can be converted to cash without incurring significant transaction costs.
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To the extent a contract provides a return based on the total return of a contractually referenced
interest rate index, the amount of other adjustments described in paragraph 18 of this SOP
should be based on the applicable index value at the balance sheet date and should anticipate no
future changes in the index value. Amounts determined for other adjustments are not reduced for
future fees and charges.8
20. For contracts that have features that may result in more than one potential account balance
(for example, a contract that provides a return based on a contractually referenced pool of real
estate assets owned by the insurance enterprise but also provides for minimum investment
return guarantees), the accrued account balance should be based on the highest contractually
determinable balance that will be available in cash or its equivalent, before reduction for future
fees and charges, at contractual maturity or the reset date. For contracts in which amounts
credited as interest to the contract holder are reset periodically, the accrued balance should be
based on the highest crediting rate guaranteed or declared through the reset date.
21. The accrued account balance should reflect no surrender adjustments (for example, market
value annuity adjustments,9 surrender charges, or credits). Any changes in the accrued account
balance resulting from the application of the guidance in paragraphs 18 through 20 of this SOP
should be reported as a charge or credit to the statement of operations.
22. No liability should be recognized during the accumulation phase for the potential effect of
annuitization options.
Determining the Significance of Mortality and Morbidity Risk and Classification of Contracts That
Contain Death or Other Insurance Benefit Features
23. To determine the accounting under FASB Statements No. 60 or 97 for a contract that
contains death or other insurance benefit features, the insurance enterprise should first determine
whether the contract is an investment or insurance contract. Classification of a contract as an
investment contract or as an insurance contract should be made at contract inception, and
classification should not be reassessed during the accumulation phase of the contract. If the
mortality and morbidity risk associated with insurance benefit features offered in a contract is
deemed to be nominal, that is, a risk of insignificant10 amount or remote11 probability, the contract
should be classified as an investment contract, otherwise it should be considered an insurance
contract. If the mortality and morbidity risk is other than nominal and the fees assessed or
insurance benefits are not fixed and guaranteed, the contract should be classified as a FASB
Statement No. 97 universal life-type contract by the insurance enterprise. If the fees assessed on
a contract or insurance benefits provided by the contract are fixed and guaranteed or if the
contract is short duration, the contract should be classified under FASB Statement No. 60, as
amended.
24. The determination of significance of mortality and morbidity risk should be based on a
comparison of the present value of expected excess payments to be made under insurance
benefit features (that is, insurance benefit amounts in excess of the account balance, herein
referred to as the “excess payments”) and related expenses with the present value of all amounts
expected to be assessed against the contract holder (revenue). For contracts that include
8

A loss should be recognized in the income statement to the extent an asset reported in the general account
is designated as part of a contractually referenced pool of assets and on that designation date has an
unrealized loss.
9
For a description of a market value annuity and market value annuity adjustments refer to Appendix D,
paragraph D1.
10
The terms “nominal” and “insignificant” are as used in FASB Statement No. 97, Accounting and
Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and
Losses from the Sale of Investments, paragraph 40.
11
The term “remote” is as defined in FASB Statement No. 5, Accounting for Contingencies.
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investment margin12 in their estimated gross profits,13 the investment margin should be included
with any other assessments for purposes of determining significance. In performing the analysis,
an insurance enterprise should consider a range of reasonably possible scenarios, rather than
making a best estimate using one set of assumptions. For example, if the annuity contract is a
variable annuity contract, the insurance enterprise should consider a range of reasonably
possible fund return scenarios. When considering a range of reasonably possible scenarios, the
insurance enterprise should consider historical investment returns, the volatility of those returns,
and expected future returns, as applicable.
25. If a reinsurer assumes the insurance benefit feature of a contract under a noncancellable or
guaranteed renewable reinsurance contract, the reinsurer should assess the significance of
mortality and morbidity risk within the reinsurance contract according to the guidance in
paragraphs 23 and 24 of this SOP, regardless of whether there is an account balance. The
reinsurer should determine classification of the reinsurance contract as an investment contract or
as a universal life-type contract at the inception of the reinsurance contract. For reinsurance
contracts, the mortality and morbidity risk could be deemed other than nominal even if the original
issuer did not determine mortality and morbidity to be other than nominal. Similarly, the issuer of
a contract that provides only an insurance benefit feature that wraps14 a noninsurance contract,
for example, a guaranteed minimum death benefit related to a mutual fund balance, should
evaluate its contract in the same manner.
Accounting for a FASB Statement No. 97 Universal Life-Type Contract With Death or Other
Insurance Benefit Features
26. For a contract determined to meet the definition of a universal life-type contract as described
in paragraphs 23 and 24, if the amounts assessed against the contract holder each period for the
insurance benefit feature are not proportionate to the insurance coverage provided for the period,
a liability should be established in addition to the account balance to recognize the portion of such
assessments that compensates the insurance enterprise for benefits to be provided in future
periods. Insurance coverage encompasses the concepts of amounts at risk and the relative
probability of mortality and morbidity events. The amount of the additional liability should be
determined based on the ratio (benefit ratio) of (a) the present value of total expected excess
payments and related expenses over the life of the contract, divided by (b) the present value of
total expected assessments over the life of the contract. Total expected assessments are the
aggregate of all charges, including those for administration, mortality, expense, and surrender,
regardless of how characterized. For contracts whose assets are reported in the general account
and that include investment margin in their estimated gross profits, the investment margin should
be included with any other assessments for purposes of determining total expected assessments.
The insurance enterprise should calculate the present value of total expected excess payments,
related expenses, and total assessments and investment margins, as applicable, based on
expected experience. Expected experience should be based on a range of reasonably possible
scenarios rather than a single set of best estimate assumptions. In calculating the additional
liability for the insurance benefit feature, assumptions used, such as the interest rate, discount
rate, lapse rate, and mortality, should be consistent with assumptions used in estimating gross
profits for purposes of amortizing capitalized acquisition costs. For contracts in which
assessments are collected over a period shorter than the period for which the contract is subject
to mortality and morbidity risks, the assessment would be considered a front-end fee under FASB
Statement No. 97 and accounted for under paragraph 20 of Statement No. 97. The amounts
recognized in income should be considered assessments for purposes of this paragraph.

12

The term “investment margin” is as defined in FASB Statement No. 97, paragraph 23(c).
The term “estimated gross profit” is as defined in FASB Statement No. 97, paragraph 23.
14
The term “wrap” refers to the practice of adding an insurance benefit feature to a separate noninsurance
contract generally from a different issuer.
13

22

27. The insurance enterprise should regularly evaluate estimates used and adjust the additional
liability balance, with a related charge or credit to benefit expense, if actual experience or other
evidence suggests that earlier assumptions should be revised. In making such revised estimates,
both the present value of total excess payments and related expenses, and the present value of
total expected assessments or investment margins, should be calculated as of the balance sheet
date using historical experience from the issue date to the balance sheet date and estimated
experience thereafter.
28. The additional liability at the balance sheet date should be equal to:
a. The current benefit ratio multiplied by the cumulative assessments15
b. Less the cumulative excess payments and related expenses (including amounts
reflected in claims payable liabilities)
c. Plus accreted interest
However, in no event should the additional liability balance be less than zero. The change in the
additional liability should be recognized as a component of benefit expense in the statement of
operations.
29. The estimated gross profits used for the amortization of deferred acquisition costs should be
adjusted to reflect the incidence of assessments and claims expense as a result of the recognition
of the liability in accordance with paragraph 28 of this SOP.
30. A reinsurer assuming a proportionate share of the entire contract containing insurance benefit
features should account for its share in accordance with paragraphs 26 through 29 of this SOP.
Accounting for Contracts That Provide Only Death or Other Insurance Benefit Features
31. For insurance or reinsurance contracts described in paragraph 25 of this SOP, the insurance
enterprise should calculate a liability for the portion of premiums collected each period that
represents compensation to the insurance enterprise for benefits to be provided in future periods.
That liability should be calculated using the methodology described in paragraphs 26 through 28
of this SOP.
Sales Inducements to Contract Holders
32. Sales inducements provided to the contract holder, whether for investment or universal lifetype contracts, should be recognized as part of the liability for policy benefits over the period for
which the contract must remain in force for the contract holder to qualify for the inducement or at
the crediting date, if earlier, in accordance with paragraph 18 of this SOP. No adjustments should
be made to reduce the liability related to the sales inducements for anticipated surrender charges,
persistency, or early withdrawal contractual features.
33. Sales inducements that (a) are recognized as part of the liability under paragraph 32 of this
SOP, (b) are explicitly identified in the contract at inception, and (c) meet the criteria in the
following sentence should be deferred and amortized using the same methodology and
assumptions used to amortize capitalized acquisition costs. The insurance enterprise should
demonstrate that such amounts are (a) incremental to amounts the enterprise credits on similar
contracts without sales inducements and (b) higher than the contract’s expected ongoing crediting
rates for periods after the inducement, as applicable; that is, the crediting rate excluding the
inducement should be consistent with assumptions used in estimated gross profits, contract
illustrations, and interest crediting strategies. The deferred amount should be recognized on the
statement of financial position as an asset, and amortization should be recognized as a
component of benefit expense. The annuitization phase is viewed as a separate contract under
15

The term “cumulative assessments” refers to actual cumulative assessments, including investment
margins, if applicable, recorded from contract inception through the balance sheet date.
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FASB Statement No. 97, and should not be combined with the accumulation phase for
amortization of deferred sales inducements and deferred acquisition costs.
Disclosures
34. The following information should be disclosed in the aggregate for separate accounts
reported as summary totals in the financial statements of the insurance enterprise:
a. The general nature of the contracts reported in separate accounts, including the
extent and terms of minimum guarantees.
b. The basis of presentation for separate account assets and liabilities and related
separate account activity, and a description of the liability valuation methods and
assumptions used in estimating the liabilities for additional insurance benefits and
minimum guarantees.
c. Disclosures should include the following amounts related to minimum guarantees:
(1) The separate account liability balances subject to various types of guarantees
(for example, return of net deposits, return of net deposits accrued at a stated
rate, return of highest anniversary value); and
(2) The amount of liability reported for additional insurance benefits and minimum
guarantees, by type of benefit or guarantee, for the most recent balance sheet
date and the effect on earnings of changes in the liability for all years presented.
d. The aggregate fair value of assets, by major investment asset category, supporting
separate accounts with additional insurance benefits and minimum investment return
guarantees as of each date for which a statement of financial position is presented.
35. An insurance enterprise should disclose its accounting policy for sales inducements, including
the nature of the costs deferred and the method of amortizing those costs. The amount of costs
deferred and amortized for each of the periods presented and the unamortized balance as of
each balance sheet date also should be disclosed. An insurance enterprise should disclose the
nature of the liabilities and methods and assumptions used in estimating any contract benefits
pursuant to paragraphs 18 and 32 of this SOP in excess of the amount credited to the contract
holder’s account.
EFFECTIVE DATE AND TRANSITION
36. The provisions of this SOP are effective for financial statements for fiscal years beginning
after December 15, 2003, with earlier adoption encouraged. Restatement of previously issued
annual financial statements or reclassification between separate account and general account
balances is not permitted. Initial application of this SOP should be as of the beginning of an
entity’s fiscal year (that is, if the SOP is adopted prior to the effective date and during an interim
period, all prior interim periods should be restated). Disclosure of the pro forma effects of
retroactive application (discussed in paragraph 21 of Accounting Principles Board (APB) Opinion
No. 20, Accounting Changes) or on the year of adoption is not required.
37. At the date of initial application:
a. For assets that no longer qualify for separate account treatment:
(1) Debt or equity securities previously classified as separate account assets but
valued in accordance with FASB Statement No. 115 should maintain their
designations as held-to-maturity, available-for-sale, or trading upon
reclassification to the general account.
(2) The provisions of FASB Statement No. 115 should be adopted for any debt
or equity securities previously recognized at fair value in accordance with
paragraph 54 of FASB Statement No. 60, as amended. Any adjustment for
FASB Statement No. 115 designation resulting from initial adoption should be
reported in a manner similar to the cumulative effect of a change in
accounting principle in accordance with the provisions of APB Opinion No. 20
and paragraph 25 of FASB Statement No. 115:
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(a) If designated as held-to-maturity, the adjustment should be reported
through income.
(b) If designated as available-for-sale, the adjustment should be reported in
income, with a corresponding cumulative effect adjustment for the
unrealized holding gains and losses reported in other comprehensive
income.
(c) If designated as trading, there should be no adjustment.
(3) Any revaluation adjustments related to assets that are not subject to FASB
Statement No. 115 should be reported in a manner similar to the cumulative
effect of a change in accounting principle in accordance with the provisions of
APB Opinion No. 20.
b. The guidance in paragraph 37(a) of this SOP should be applied in accounting for an
insurance enterprise’s proportionate interest in the separate account assets
regardless of whether the interest was previously reported in the separate account or
the general account. If the insurance enterprise considered its portion of separate
account units to be equity securities under FASB Statement No. 115, the guidance in
paragraph 37(a)(1) or (3) should be applied as appropriate.
c. To the extent a debt or equity security subject to FASB Statement No. 115 and
previously classified as available-for-sale is part of a contractually referenced pool of
assets in which total return will be accrued to the account balance (in accordance
with paragraph 19 in this SOP), and a transition adjustment for the liability valuation
is reported in accordance with (e), that security may be reclassified to trading with the
revaluation adjustment recognized as a cumulative effect similar to the liability
transition adjustment.
d. For contracts that are in force on the date of initial application of this SOP, the
determination of significance of mortality and morbidity risk resulting from insurance
benefit features, in accordance with paragraphs 23 through 25 in this SOP, should be
performed as of the date of initial application of this SOP using both actual results
from inception of the contract through the date of initial application and expected
future results thereafter.
e. Any adjustment in contract holder liabilities from adopting this SOP should be
reported in a manner similar to the cumulative effect of a change in accounting
principle in accordance with the provisions of APB Opinion No. 20, through income
or, for amounts previously accrued under Emerging Issues Task Force (EITF) Topic
No. D-41, Adjustments in Assets and Liabilities for Holding Gains and Losses as
Related to the Implementation of FASB Statement No. 115, accumulated other
comprehensive income.
f.
If the adoption of this SOP results in changes in estimated gross profits, any
adjustments to unamortized deferred acquisition costs or present value of future
profits16 should be reported in a manner similar to the cumulative effect of a change
in accounting principle in accordance with the provisions of APB Opinion No. 20,
through income or, for amounts previously accrued under EITF Topic No. D-41,
accumulated other comprehensive income.
38. This SOP should be applied prospectively with respect to the deferral of sales inducements
meeting the criteria in paragraph 33 of this SOP. Sales inducements deferred subsequent to the
initial application of this SOP on policies in force at that date should be accounted for in
accordance with paragraph 33 of this SOP. Costs recognized for sales inducements prior to initial
application of this SOP other than for those referred to in paragraph 39 of this SOP, whether
capitalized or not, should not be adjusted to the amounts that would have been deferred had this
SOP been in effect when those costs were incurred. Costs capitalized for sales inducements prior
to initial application of this SOP that were previously reported with unamortized deferred
acquisition costs should be reported separately.
16

As discussed in Emerging Issues Task Force (EITF) Issue No. 92-9, Accounting for the Present Value of
Future Profits Resulting from the Acquisition of a Life Insurance Company.
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39. Insurance enterprises that were previously amortizing sales inducements using the same
methodology and assumptions used for amortizing deferred acquisition costs (the approach
required by the guidance in this SOP) should continue using that approach and should consider
the entire life of the contracts. Any cumulative adjustment to unamortized sales inducements
resulting from changes in estimated gross profits, made as a result of the initial adoption of this
SOP, should be reported in a manner similar to the cumulative effect of a change in accounting
principle in accordance with the provisions of APB Opinion No. 20, through net income or, for
amounts previously accrued under EITF Topic No. D-41, accumulated other comprehensive
income. However, if an insurance enterprise had been amortizing sales inducements using a
methodology or assumptions other than those used for amortizing deferred acquisition costs, the
amortization of deferred sales inducements after implementation of this SOP should consider only
estimated gross profits or interest, as applicable depending on the amortization methodology,
from the date of initial application forward.
The provisions of this Statement need not be applied to immaterial items.
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APPENDIX A
BASIS FOR CONCLUSIONS

Separate Account Presentation
A1. Existing authoritative accounting guidance for separate accounts is limited to paragraphs 53
and 54 of Financial Accounting Standards Board (FASB) Statement of Financial Accounting
Standards No. 60, Accounting and Reporting by Insurance Enterprises, and was written when
contracts underlying the separate accounts generally were either fixed (having guaranteed
returns) or variable (wherein the performance of the assets was the sole determinant of the return
to the contract holder):
53.
Separate accounts represent assets and liabilities that are maintained by
an insurance enterprise for purposes of funding fixed-benefit or variable annuity
contracts, pension plans, and similar activities. The contract holder generally
assumes the investment risk, and the insurance enterprise receives a fee for
investment management, certain administrative expenses, and mortality and
expense risks assumed.
54.
Investments in separate accounts shall be reported at market except for
separate account contracts with guaranteed investment returns. For those
separate accounts, the related assets shall be reported in accordance with
paragraphs 45-51 [that is, accounted for the same as other general account
investments]. Separate account assets and liabilities ordinarily shall be reported
as summary totals in the financial statements of the insurance enterprise.
A2. Paragraph 54 of FASB Statement No. 60 has not been applied consistently in practice in
terms of valuing assets maintained in separate accounts that have been determined to require
valuation as general account assets, and in classifying the assets in the insurer's statement of
financial position. It is unclear whether the phrase "reported in accordance with paragraphs 4551," as used in paragraph 54 of FASB Statement No. 60, refers only to valuation or whether it
refers to statement of financial position single line presentation as well. Paragraph 54 of FASB
Statement No. 60 states that “Separate account assets and liabilities ordinarily shall be reported
as summary totals in the financial statements of the insurance enterprise.” Because separate
account liabilities are classified consistent with the related asset classification, the issue of
classification also affects separate account liabilities.
A3. Although FASB Statement No. 60, as amended, requires separate account assets and
liabilities to be reported in the financial statements of the insurance enterprise, the Accounting
Standards Executive Committee (AcSEC) considered whether that guidance is consistent with
recent standards dealing with both asset and liability recognition and derecognition, such as
FASB Statement No. 140, Accounting for Transfers and Servicing of Financial Assets and
Extinguishments of Liabilities. AcSEC also considered potential analogies to similar trust fund and
mutual fund products offered by the financial services industry. AcSEC noted that, unlike a
financial institution trust fund account or mutual fund, the assets of the separate account are
legally owned by the insurance enterprise. Additionally, a separate account is not a separate legal
entity under general corporate statutes. As noted in the AICPA Audit and Accounting Guide Life
and Health Insurance Entities, “a separate account is a legally restricted fund that is segregated
from the life insurance entity. State insurance laws provide that assets in separate accounts may
be invested without regard to restrictions covering general investments of life insurance entities.
Separate account assets are generally not available to cover liabilities except those of the
separate account.”
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A4. Thus, separate account assets may be isolated from the general creditors of the insurance
enterprise, but not from the insurance enterprise itself, which still legally owns the assets. In a
variable annuity or similar arrangement, there is no relinquishment of ownership of assets but
rather the execution of a contract pursuant to which the insurance enterprise agrees to pass
through the separate account investment results to the contract holder. Furthermore, the contract
executed between the contract holder and the insurance enterprise creates an obligation of the
insurance enterprise that is not defeased by the segregation of funds in the separate account.
Based on the above, AcSEC concluded that separate account assets and separate account
liabilities should be reported in the statement of financial position of the insurance enterprise that
owns the assets and is contractually obligated to settle the liabilities.
A5. AcSEC considered whether the separate account asset and liability reporting requirements of
FASB Statement No. 60, as amended, should be retained in light of AcSEC’s recent conclusion in
the SOP 00-3, Accounting by Insurance Enterprises for Demutualizations and Formations of
Mutual Insurance Holding Companies and for Certain Long-Duration Participating Contracts, that
closed block assets, liabilities, and related statement of operations activity should be displayed
with the remainder of an insurance enterprise’s assets, liabilities, and statement of operations
activity. AcSEC concluded that separate account structures differ in several significant respects
from closed block structures: closed blocks do not legally insulate the assets supporting contract
liabilities, closed block contract holders do not direct the investment of supporting assets, and
individual closed block contract holders do not receive the direct pass-through of investment
performance.
A6. Collectively, the unique features of separate account arrangements warrant presentation
distinct from an insurance enterprise’s other assets and liabilities. AcSEC concluded that
summary account totals in the statement of financial condition and the offsetting of investment
performance and corresponding amounts credited to the contract holder provide the most
meaningful presentation to the users of the financial statements for contracts meeting the four
criteria specified in paragraph 10 of this SOP. In addition, this presentation allows financial
statement users to more readily analyze investment returns of insurance enterprises by excluding
amounts that are legally insulated from the general account and not available to shareholders.
A7. Separate accounts often are used in conjunction with nontraditional products that have both
fixed and variable features. For example, variable annuity and variable life contracts frequently
offer fixed rate investment options (typically through the insurer’s general account) and may
provide contractually guaranteed benefits that are paid upon the death of the contract holder
(minimum guaranteed death benefits) or at a specified date in the accumulation phase of the
contract (guaranteed minimum accumulation benefits). Those products have made it difficult to
determine whether the criterion in paragraph 53 of FASB Statement No. 60, that “the contract
holder generally assumes the investment risk” has been met and thus whether assets and
liabilities associated with such separate account arrangements should be classified as general
account, separate account, or some combination of both. In addition, fixed contracts in which the
insurance enterprise guarantees investment return or otherwise bears the investment risk may be
offered through separate accounts, for example, as a means to provide additional credit
protection to the contract holder.
A8. AcSEC believes that the emergence of new products has created a need for criteria to be
developed for evaluating separate account arrangements and applying the guidance in
paragraphs 53 and 54 of FASB Statement No. 60. AcSEC concluded that a defining characteristic
of separate accounts is their designation as such by appropriate regulatory bodies. AcSEC also
believes that legal insulation of separate account assets, such that to the extent of contract holder
liabilities, the assets would not be available to the general creditors and shareholders of the
insurance enterprise in the event of insolvency, is a unique aspect of separate account assets.
AcSEC also concluded that a defining characteristic of separate accounts is that the contract
holder dictates the allocation of deposits among investment alternatives and receives the passthrough of investment performance (that is, the contract holder bears the investment risk). In the
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case of certain group contracts, this feature may take the form of the contract holder’s
establishment of specific investment guidelines and objectives.
A9. AcSEC considered whether only the assets and liabilities associated with the pure passthrough contracts offered through separate account arrangements, such as traditional variable
annuities and other variable contracts that have neither guaranteed minimum death benefits nor
accumulation guarantees, should be presented as single line items in the statement of financial
condition of an insurance enterprise. That treatment would require that the insurer not include in
the separate account summary totals the assets and liabilities related to a contract if the
insurance enterprise bore any investment risk related to that contract. That view was rejected
because the contract holder, rather than the insurance enterprise, controls the investments and is
entitled to all the rewards of owning the assets underlying variable contracts. AcSEC concluded
that separate account presentation for the portion of the separate account arrangement meeting
the four criteria specified in paragraph 10 of this SOP is appropriate. Guarantees on such
contracts provided by the insurance enterprise are viewed as incremental contract benefits that
may require recognition of any additional liability in the general account of the insurance
enterprise.
Accounting for an Insurance Enterprise’s Interest in a Separate Account
A10.
When a separate account is established, the insurance enterprise may transfer noncontract-holder-related funds, commonly referred to as seed money, from its general account to
the separate account to support the initial or ongoing operations of the separate account. Such
transfers give the insurance enterprise an ownership interest in the separate account. The
insurance enterprise’s interest may also include undistributed earnings on the seed money and
contract charges that have not been transferred to the general account.
A11.
AcSEC recognized that there was diversity in practice regarding the classification and
measurement of an insurance enterprise's proportionate interest in a separate account. Some
insurance enterprises classified such amounts in the separate account caption along with
separate account assets attributable to contract holders. Other insurance enterprises reclassified
such amounts to general account assets. In terms of measurement, some insurance enterprises
marked separate account assets to market through income, including the insurance enterprise’s
proportionate interest, while others accounted for the insurance enterprise’s proportionate interest
as general account assets. Some insurance enterprises viewed the separate account as if it were
a separate legal entity, and thus considered their portion of "separate account units" to be equity
securities. Other insurance enterprises looked through the separate account arrangement and
viewed their investment as a proportionate interest in the underlying mutual funds, debt and
equity securities, mortgage loans, real estate, or other assets in which the separate account
arrangement was invested.
A12.
AcSEC concluded that an insurance enterprise’s proportionate interest in the assets of a
separate account does not qualify for separate account treatment, as it does not represent
contract holder funds. Consequently, the assets underlying the insurance enterprise’s
proportionate interest should be classified and measured as general account assets in
accordance with paragraphs 45 through 51 of FASB Statement No. 60, as amended.
A13.
AcSEC noted that a separate account is not a distinct legal entity under general corporate
statutes, but rather an accounting entity created by and under the control of the insurance
enterprise that owns 100 percent of the assets. The insurance enterprise’s proportionate interest
in the separate account typically would be available to general creditors in the event of the
insurance enterprise’s insolvency. AcSEC concluded that an insurance enterprise’s proportionate
interest in a separate account should not be viewed as an investment in "equity securities" of the
separate account. Instead, AcSEC concluded that the insurance enterprise should “look through”
to the underlying investments held in the separate account for purposes of classification and
measurement as general account assets. In drawing that conclusion, AcSEC believed that assets
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should not be accounted for differently depending on whether an insurance enterprise has an
interest in those assets through the general account or through the separate account (for
example, fair value versus historical cost for real estate).
A14.
Contract holders may have the right to continue to make deposits and direct transfers of
their account balances and new contract holders are permitted to invest in the various separate
account arrangements. In those cases, the insurance enterprise is effectively holding for sale its
proportionate interest in the separate account if those separate account arrangements would
meet the criteria in paragraph 10 of this SOP. Consequently, the insurance enterprise should
recognize an impairment loss on its proportionate interest in a separate account arrangement
meeting the criteria in paragraph 10 in a situation where the current fair value of the insurance
enterprise’s proportionate interest in the separate account assets is less than its carrying amount.
Transfers to Separate Accounts
A15.
AcSEC concluded that transfers of assets to separate accounts should be recognized at
fair value to the extent of third-party contract holders’ beneficial interests in the separate account
if the separate account arrangement meets the criteria in paragraph 10 of this SOP, with any
resulting gains or losses recognized immediately in earnings of the insurance enterprise. Gain or
loss recognition is appropriate in such cases because the contract holders are unrelated third
parties to whom subsequent risks and rewards of ownership of a portion of the asset has been
transferred, and the assets will subsequently be carried at fair value with changes reported in
earnings (offset by changes in contract holder liabilities). Furthermore, although the insurance
enterprise holds legal title to assets in separate account arrangements, the contract holders will
be entitled to receive the investment performance of the assets after the transfer. This treatment
is consistent with the presentation of separate account assets as summary totals in the statement
of financial position, because the risks and rewards of ownership of the assets reside with the
contract holders rather than the insurance enterprise that has legal ownership of the assets. If the
insurance enterprise guarantees the asset’s value or minimum rate of return or commits to
repurchase the asset, the risks of ownership have not been transferred, and no gain should be
recognized. However, loss recognition is still appropriate as noted in paragraph A14 of this SOP.
Valuation of Liabilities
Account Balance
A16.
FASB Statement No. 97, Accounting and Reporting by Insurance Enterprises for Certain
Long-Duration Contracts and for Realized Gains and Losses from the Sale of Investments, does
not explicitly define “the balance that accrues to the benefit of policyholders at the date of the
financial statements” (FASB Statement No. 97, paragraph 17(a)), commonly referred to as the
“account balance.” FASB Statement No. 97, paragraph 18, provides that the account balance is
an amount that should not be reduced for “amounts that may be assessed against policyholders
in future periods, including surrender charges….”
A17.
AcSEC also noted that FASB Statement No. 97 defines contract holder balance indirectly
through the following:
Premium payments are credited to the policyholder balance, against which amounts
are assessed for contract services and to which amounts are credited as income.
The policyholder balance provides a base upon which interest accrues to the
policyholder and, when compared with the death benefit amount, fixes the insurer’s
net amount at risk. [paragraph 45]
...the balance that accrues to the benefit of individual policyholders represents the
minimum measure of an insurance enterprise’s liability.... For many universal lifetype contracts, this amount takes the form of an account balance that, absent future
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action by the policyholder, will continue to fund operation of the contract until
exhausted or reduced to a contract minimum. The insurer has a present obligation,
arising from past transactions, to continue to maintain the contract and provide
mortality protection as long as an adequate account balance exists. Other universal
life-type contracts do not have an explicit policyholder account but do have a
policyholder balance to which interest is accrued at a variable rate. In either case,
future events and transactions will change the amount of the enterprise’s obligation
as policyholders make additional premium deposits and realize contract benefits.
The present obligation, however, is fixed by the amount that has accrued to the
benefit of the policyholder. [paragraph 53]
Recent product innovation and the lack of explicit guidance has led to diversity in the application
of the definition of account balance. AcSEC therefore believes that interpretive guidance is
needed for determining the balance that accrues to the benefit of the policyholder at the date of
the financial statements.
A18.
AcSEC concluded that all surrender charges or credits should be ignored in measuring
the policyholder liability because, as noted in FASB Statement No. 97, paragraphs 18 and 53, the
liability should be measured assuming no future action by the policyholder. FASB Statement No.
97 is a long-duration contract model that does not assume policyholders will surrender at the
balance sheet date but rather amortizes deferred acquisition costs over the expected life of the
contract. Additionally, the FASB Statement No. 60, as amended, and FASB Statement No. 97
accounting models do not require the contract holder liability, net of unamortized acquisition
costs, to equal or exceed the cash surrender value of the contract. AcSEC considered whether
the presence of an additional amount due on surrender but not due upon maturity, such as a
market value annuity adjustment, should merit an additional liability. AcSEC concluded that
recording an additional liability for surrender adjustments prior to the contract holder’s elected
surrender would be inconsistent with the long-duration model.
A19.
AcSEC concluded that in accordance with FASB Statement No. 97 it is appropriate to
accrue to the amount that the contract holder could receive in cash or its equivalent, before
reduction for future fees and charges, at the earlier of the date that the rate credited to the
contract is reset or contractual maturity. That conclusion is consistent with the long-duration
model, which does not permit the anticipation of surrenders and also with the accounting for debt
instruments, under which interest is accrued to maturity using the interest method. Accrual of
interest at an effective interest rate is consistent with existing accounting for debt instruments with
fixed non-level interest payments. A delay in crediting to the contract holder account balance of
an amount that is to be credited in the future should not prevent the accrual of the amount ratably
over the period the contract holder earns the amount.
A20.
AcSEC believes that a contract for which the amount due at maturity is based on a
referenced pool of assets is similar to indexed debt, which prior to FASB Statement No. 133,
Accounting for Derivative Instruments and Hedging Activities, was accounted for using Emerging
Issues Task Force (EITF) Issue No. 86-28, Accounting Implications of Indexed Debt Instruments.
EITF Issue No. 86-28 provides the following accounting guidance:
... as the applicable index increases such that the issuer would be required to pay
the investor a contingent payment at maturity, the issuer should recognize a
liability for the amount that the contingent payment exceeds the amount, if any,
originally attributed to the contingent payment feature. The liability for the
contingent payment feature should be based on the applicable index value at the
balance sheet date and should not anticipate any future changes in the index
value. When no proceeds are originally allocated to the contingent payment, the
additional liability resulting from the fluctuating index value should be accounted
for as an adjustment of the carrying amount of the debt obligation.
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Therefore, AcSEC concluded that, to the extent such contracts are not accounted for under the
provisions of FASB Statement No. 133, the balance that accrues to the benefit of the contract
holder should be based on the fair value of the referenced pool of assets because the change in
the fair value of the referenced pool of assets represents the change in the account balance. To
the extent the amount credited does not equal the change in fair value of the referenced pool of
assets, an adjustment as per paragraph 18(e) of this SOP would be required.
Annuitization Options
A21.
Certain variable annuities provide a guaranteed minimum amount available to annuitize
after a specified period in addition to a guaranteed minimum annuity interest rate. Other contracts
may provide a lower tier crediting rate during the accumulation phase and a higher rate that is
available only upon annuitization. There was diversity in practice with regard to the accounting for
these and other annuitization options.
A22.
FASB Statement No. 97, paragraph 7, states in part that “A contract provision that allows
the holder of a long-duration contract to purchase an annuity at a guaranteed price on settlement
of the contract does not entail a mortality risk until the right to purchase is executed. If purchased,
the annuity is a new contract to be evaluated on its own terms.” Some believe that statement
precludes accounting recognition of an annuitization option before that option is exercised.
Others, noting that an annuitization option is a potential economic benefit to contract holders
incorporated into an existing contract, believe that it should be given accounting recognition.
AcSEC concluded that the most appropriate interpretation of the guidance in paragraph 7 of
FASB Statement No. 97 would prohibit the recognition of a liability related to any such options. An
annuitization option is an elective benefit that is not part of the accumulation phase of an
annuity contract, but instead is payable as part of the annuitization phase of the contract. In
contrast, minimum death benefit guarantees, long-term care (LTC) benefits, and other mortality
or morbidity related benefits offered prior to annuitization are part of the accumulation phase of
the contract and, therefore, accruable under FASB Statement No. 97. In reaching a conclusion
relative to accounting for annuitization option benefits, AcSEC considered several alternative
models, including loan commitment model, written option model, and cost model. AcSEC’s
consideration of those models is discussed in the following paragraphs of this SOP.
A23.
Consideration of the Loan Commitment Model. AcSEC considered an analogy between
annuitization options provided to contract holders and loan commitments offered to borrowers,
the accounting for which is prescribed by FASB Statement No. 91, Accounting for Nonrefundable
Fees and Costs Associated with Originating or Acquiring Loans and Initial Direct Costs of Leases,
which effectively defers revenue recognition until the economic sacrifice has occurred. FASB
Statement No. 91 states in paragraph 8 “…fees received for a commitment to originate or
purchase a loan or group of loans shall be deferred and, if the commitment is exercised,
recognized over the life of the loan as an adjustment of yield….” Under this analogy, all fees
related to an annuitization option should be deferred until the contract holder selects an annuity
option, the fees would then be recognized over the payout phase of the annuity, or if annuitization
was not elected, recognized in income at the date the contract is surrendered.
A24.
AcSEC believes that problems would arise in applying the loan commitment model to
annuity contracts. First, it would be difficult to reasonably determine which fees should be
deferred within a fee-based product as the fees related to the annuitization guarantee often are
not stated explicitly, or even if stated explicitly, may have been priced on an integrated basis with
other revenue components within the contract rather than on a stand-alone basis. Also, it is
unclear how to apply this model to products where the insurance enterprise derives its income
from investment spreads and thus the contracts have no explicit fee of any kind to defer.
A25.
In addition, AcSEC noted that there are differences between annuitization options and
loan commitments. Annuitization options are of a long-term nature (for example, the contract
holder may have until age 90 or 100 to annuitize), whereas a loan commitment is generally for a
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much shorter period. Also, in deciding whether or not to annuitize, there are additional economic
factors that contract holders must consider, such as alternative investment options, cash flow
considerations, their tax situations, and needs of beneficiaries. Those factors are not relevant to
the process of taking a loan, as the commitment is entered into with the intent to borrow and the
principal decision is whether the loan terms are competitive. In view of the significant practical
implications and many differences between annuitization options and loan commitments, AcSEC
decided to reject the FASB Statement No. 91 approach in accounting for annuitization and similar
elective benefits.
A26.
Consideration of the Written Option Model. AcSEC also considered whether elective
benefit options should be accounted for as written options by recording the fair value of the
options both at inception and throughout the accumulation phase of the contract, with changes in
fair value recognized in income. Supporters of this view believe that annuitization options with
significant economic value at inception were not contemplated when FASB Statement No. 97 was
deliberated, thus challenging the interpretation of FASB Statement No. 97, paragraph 7, that
annuitization options are not given accounting recognition during the accumulation phase of the
annuity contract. FASB Statement No. 97 states in paragraph 40 that “…The risk that the
guaranteed price of an annuity may prove to be unfavorable to the guaranteeing enterprise when
the annuity is purchased is a price risk not unlike a guaranteed price of any commodity and does
not create a mortality risk [emphasis added].” Some believe that, although that guidance prohibits
accounting for the contract as if the payout phase were elected and mortality risk existed, it
acknowledges the existence of price risk inherent in the annuitization option, thereby potentially
allowing for the recognition of the effect of significant annuitization options in the accumulation
phase.
A27.
AcSEC also noted that under FASB Statement No. 133 reinsurance of a guaranteed
minimum income benefit (GMIB) option would typically be accounted for as a derivative
contract by both the direct writer of the deferred annuity contract with the GMIB feature (ceding
company) and the reinsurer, as such reinsurance contracts are typically net settled. Also,
although the FASB has concluded that certain annuitization options such as GMIBs offered in
direct annuity contracts typically are not net settled and therefore fall outside the scope of FASB
Statement No. 133, some argue that there are written options that fall outside the scope of FASB
Statement No. 133 that nevertheless are required to be fair valued. For example, EITF Issue No.
99-2, Accounting for Weather Derivatives, requires fair value for certain written options even
though they fall outside the scope of FASB Statements No. 133 and No. 138, Accounting for
Certain Derivative Instruments and Certain Hedging Activities. However, those are examples of
contracts falling outside of the scope of Statement No. 133 and No. 138 that represent written
options in their entirety and not a component embedded in a contract.
A28.
AcSEC noted that an annuitization guarantee is a price risk.1 In today’s accounting
models unless a price guarantee constitutes a FASB Statement No. 133 derivative or is otherwise
covered by specific accounting literature, it receives no accounting recognition. AcSEC continues
to believe the most appropriate interpretation of the guidance in paragraph 7 of FASB Statement
No. 97 would prohibit the recognition of any liability related to an annuitization guarantee. It was
also noted that following the approach of valuing all elective options would be a change in
practice and would require insurance enterprises to determine the fair value of every available
annuitization option. Traditional annuity purchase options may have little value, but it would be
necessary to continuously determine their value. AcSEC also discussed the issue of there not
being any ready market to determine the fair value of the annuity options as each contract’s
features are unique by product as well as by insurance enterprise, and the difficulty involved in

1

The Financial Accounting Standards Board (FASB) currently has an exposure draft of a proposed
interpretation, Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect
Guarantees of Indebtedness of Others—an interpretation of FASB Statements No. 5, 57 and 107. Readers
should be alert to any final pronouncement.
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splitting apart an integrated fee-based contract to determine applicable fees representing the
implicit option premium received, adding to the practical problems of applying this approach.

A29. Consideration of the Annuitization “Cost” Model. Some AcSEC members believed that
recording a liability during the accumulation phase of a contract for expected annuitization
benefits would better reflect the economics of the contract for certain products. They argued that
because some amount of revenue or fees was explicitly, or in some cases implicitly, being
charged for this additional contract feature, the cost of providing the potential future benefits
should also be recognized in the accumulation phase. They argued that the annuitization benefit
promised was similar in many respects to the guaranteed minimum death benefit feature for
which an additional liability would be recognized under the proposed SOP model. Both represent
a minimum guaranteed amount on a variable account balance, with the only difference being that
one is promised upon death, the other upon annuitization.
A30.
AcSEC ultimately concluded that despite any potential economic benefit inherent in these
contract provisions, as previously noted, FASB Statement No. 97 views the annuitization option
as an elective benefit that is not part of the accumulation phase of the contract for accounting
purposes. In addition, AcSEC could not identify an appropriate model for estimating the amount of
any potential additional liability, noting that there was no clear way to define and measure the
“cost” of such benefit. For example, a present value of cash flows model was considered, but
questions were raised as to the appropriate factors to use for such assumptions as the future
incremental annuitization benefits, discount rate, mortality, and probability of annuitization.
Contracts With Death or Other Insurance Benefit Features
Determination of Applicable Accounting Standard
A31.
AcSEC decided the FASB Statement No. 97 universal life model should only apply to
insurance benefit features (a) where the fees assessed and the benefits provided are not fixed
and guaranteed, and (b) where the mortality and morbidity risks are other than nominal. Those
contracts having insurance benefit features where the fees assessed and the benefits provided
are fixed and guaranteed should be accounted for under FASB Statement No. 60, as amended.
Those insurance benefit features that do not pass the test of significance result in the contracts
being classified as investment-type contracts under FASB Statement No. 97, and no additional
liability should be provided, other than a claim liability resulting from the occurrence of the
insurance event.
Determining the Significance of Mortality and Morbidity Risk
A32.
AcSEC considered how the test of significance of mortality and morbidity risk should be
applied to contracts with insurance benefit features. The significance test contained in paragraph
8 of FASB Statement No. 97 is based on the present value of the expected life contingent
payments relative to the present value of all expected payments. AcSEC considered whether this
test should be modified for insurance benefit features offered with annuity contracts. The test was
written for payout annuities for which the entire deposit may be subject to mortality risk. For
accumulation-phase annuity contracts containing insurance benefit features, the contract has a
deposit element, which under all circumstances the contract holder will receive, and a mortality
and morbidity element for payments in excess of the deposit element. AcSEC decided that
because the timing and nature of benefit payments are different between payout annuities and an
accumulation-phase annuity with an MGDB or other insurance benefit feature, the measurement
of the significance of the mortality related payments needed to be modified. AcSEC believes a
better method to determine significance for these contracts is to compare the present value of
expected insurance benefit excess payments with the fee revenue or spreads the insurance
enterprise will collect for accepting that and other risks. AcSEC also considered using a
rebuttable presumption that MGDB or other insurance benefit features were always other than
nominal, but rejected this as not consistent with paragraph 8 of FASB Statement No. 97.
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A33.
AcSEC considered whether the test of significance should be performed only at the
inception of the contract or throughout the life of the contract. It was noted that performing the test
throughout the life of the contract could result in situations where contracts would switch from one
accounting model to another and potentially back again as the estimate of expected benefit costs
changed. AcSEC decided to require the test of significance to be performed only at the inception
of the contract or reinsurance contract, noting that it is consistent with current practice for
applying the test for classifying payout annuities under FASB Statement No. 97. As discussed in
the transition section of this SOP, an exception is made for contracts in force at the date of
transition for which the test of significance would be performed as of transition.
A34.
For certain contracts with insurance benefit features, such as MGDBs offered with
variable annuities, the expected benefit costs or the expected revenue vary with market elements
such as interest rates or the performance of an underlying pool of equities. AcSEC considered
whether to require expected benefit costs and expected revenue to be determined based on a
single set of assumptions or a range of reasonably possible results. AcSEC decided that the test
of significance should be based on models that use more than a single set of assumptions,
because this approach would better reflect the effect of market elements on both expected benefit
costs and expected revenue. This approach is consistent with FASB Statement of Financial
Accounting Concepts No. 7, Using Cash Flow Information and Present Value in Accounting
Measurements, which concludes that expected values are more useful for present value
calculations, and is further supported by FASB Statement No. 113, Accounting and Reporting for
Reinsurance of Short-Duration and Long-Duration Contracts, which states that when evaluating
the possibility of the reinsurer incurring a loss, reasonably possible scenarios should be
considered.
Establishment of an Additional Liability
A35.
AcSEC considered whether, under the universal life model of FASB Statement No. 97, a
separate liability in addition to the account balance should be recognized. AcSEC noted FASB
Statement No. 97, paragraph 17, states: “the liability for policy benefits for universal life-type
contracts shall be equal to the sum of: a) the balance that accrues to the benefit of policyholders
at the date of the financial statements, b) any amounts that have been assessed to compensate
the insurer for services to be performed over future periods, c) any amounts previously assessed
against policyholders that are refundable on termination of the contract, d) any probable loss
(premium deficiency) as described in paragraphs 35-37 of Statement No. 60.”
A36.
AcSEC noted that the universal life model under FASB Statement No. 97 requires
additional liabilities for revenue assessed for services to be performed in future periods and any
probable future loss (premium deficiency). In studying the attributes of contracts with insurance
benefit features, AcSEC observed that, in some contracts, periodic charges are not assessed in
proportion to the risk associated with these benefit features. For example, charges may be
assessed for a ratchet MGDB offered with variable annuities based on a percentage of the
account balance. In such an MGDB design, as the account balance and assessments increase,
the likelihood of a death benefit payment in excess of the account balance decreases. AcSEC
noted FASB Statement No. 97, paragraph 61, states, “An amount assessed might be considered
unearned, for example, if it is assessed only in certain contract periods or in a manner that is
expected to result in current profits and future losses from a specific contract function.” AcSEC
concluded that, for contracts where amounts assessed against contract holders each period for
the insurance benefit feature are not proportionate to the insurance coverage provided for the
period, a liability should be established in addition to the account balance. This conclusion is also
appropriate when considering the reinsurer that assumes, under a long-duration contract, the
MGDB risk for a level basis point charge but does not assume the account balance. Without this
conclusion, the reinsurer would be recognizing revenue without the related expected benefit cost.
A37.
AcSEC also considered, but rejected, the view that an additional liability for expected
losses on insurance benefit payments would only be established if all the margins of the product
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combined to create a premium deficiency. The premium deficiency concept would in most cases
result in no additional liability being established and all amounts assessed during the period being
recognized in income even for assessments that are clearly not proportionate to the risk borne by
the insurance enterprise for the period. This is inappropriate because such disproportionate
assessments are made in part to compensate the insurance enterprise for the risk it assumes in
future periods.
A38.
In calculating the liability for the insurance benefit feature, AcSEC decided it is
appropriate to use assumptions, such as the interest rate, lapse rate, and mortality, consistent
with those used in estimated gross profits and consequently the amortization of deferred
acquisition costs. This approach is supported by paragraph 20 of FASB Statement No. 97.
A39.
Due to multiple contractual designs, some of which may include no explicit fee for the
insurance benefit feature, AcSEC concluded that the liability in addition to the account balance
should be based on total assessments, including investment spread, to eliminate different design
features receiving different accounting treatment. This approach implicitly assumes that the
assessment each period for the insurance benefit feature is a level amount of the total basis point
charge. AcSEC noted that this approach is relatively easy to apply for all contracts even if there is
not a separate explicit charge in the contract for the insurance benefit feature. If there is a
separate explicit charge for the insurance benefit feature, AcSEC still believes it is appropriate to
determine the liability using total assessments because it will result in more consistent application
of the methodology.
A40.
The additional liability is a FASB Statement No. 60 policyholder benefit liability but with
the unlocking of assumptions each period as required under FASB Statement No. 97 to recognize
the variability of the insurance benefit payments and contract assessments. That is, the FASB
Statement No. 60 policy benefits liability is calculated as the present value of future expected
benefits and related expenses minus the present value of future net premiums. In substance, the
FASB Statement No. 60 approach is a type of unearned revenue model, although the
policyholder benefit liability does not include a profit margin, in that it provides for the addition to
the policyholder benefit reserve each period of a constant percentage of gross premium. AcSEC
considered whether the additional liability should be reflected as unearned premium. The concept
of unearned revenue includes an element of profit margin, other than in a FASB Statement No. 60
policyholder benefit liability. Allocation of profit to specific contract features such as an MGDB
would require allocation of costs across all product features. Such analysis would require further
actuarial modeling of costs for other product features considering a range of assumptions, which
would add substantial effort to the determination of the MGDB liability. Such analysis to ascertain
a profit margin for each benefit feature reconciling to the total profit margin for the contract
introduces further subjectivity into the liability determination. The additional liability required in this
SOP is based on the relationship of total expected benefits and related expenses to total
expected revenue and thus is consistent with the FASB Statement No. 60 policyholder benefit
liability with the unlocking of assumptions each period to be consistent with FASB Statement No.
97. Therefore AcSEC concluded that, because profit margin was not being considered in the
calculation, the best presentation of the liability would be as a policyholder benefit liability.
Statement of Operations Presentation
A41.
AcSEC considered whether changes in the liability for insurance benefit features offered
with annuity contracts should be reflected in the statement of operations as an increase or
decrease in revenue or expense. AcSEC concluded for the reasons mentioned in paragraph A40
of this SOP, that the change in the liability should be reported as a benefit expense.
Accounting for Contracts That Provide Only Death or Other Insurance Benefit Features
A42.
FASB Statement No. 113, paragraph 12, requires that, for long duration contracts, the
reinsurance contract subjects the reinsurer to the “reasonable possibility that the reinsurer may
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realize significant loss from assuming insurance risk as that concept is contemplated in FASB
Statement Nos. 60 and 97.” Therefore, AcSEC concluded that the reinsurer should follow the
same guidance as a direct writer when testing for significance of mortality and morbidity risk and
when accounting for the insurance benefit feature.
Sales Inducements to Contract Holders
A43.
Sales inducements to contract holders typically can be characterized as one of the
following types: immediate, persistency, and enhanced crediting rate. Economically, recovery of
the costs associated with sales inducements is predicated on a future income stream of items
such as fees charged against the assets, investment margins, surrender charges, cost of
insurance charges, or reduction of other cost components. In some cases, insurance enterprises
may accept lower margins on the product. Sales inducements may be part of an arrangement
whereby the sales agent is willing to accept lower commissions, which may offset some or all of
the associated cost. In some cases, inducement programs may be initiated to prevent recognition
of more dramatic losses if the insurance enterprise is unable to retain contract holders (for
example, the insurance enterprise may be required to sell investments at a loss to fund contract
surrenders). The actual structure of the inducement can take many forms.
Consideration of the Debt Model
A44.
Asset accumulation products accounted for pursuant to FASB Statement No. 97 as
investment products or universal life-type contracts are viewed as financial instruments. The
insurance enterprise has a contractual obligation to deliver cash and the customer has a
contractual right to receive cash. Paragraph 15 of FASB Statement No. 97 requires that
investment contracts issued by an insurance enterprise be accounted for in a manner consistent
with the accounting for interest-bearing instruments.
A45.
AcSEC believes instruments issued by financial institutions should be accounted for
consistently, as noted in FASB Statement No. 97, paragraph 39: “While many investment
contracts are issued primarily by insurance enterprises, the Board believes that similar financial
instruments should be accorded similar treatment regardless of the nature of the issuing
enterprise.” In connection with an immediate inducement, cash is given to the insurance company
in exchange for a promise to pay back an amount in excess of the cash received. Paragraph 11
of Accounting Principles Board (APB) Opinion No. 21, Interest on Receivables and Payables,
states that “when a note is received or issued solely for cash and no other right or privilege is
exchanged, it is presumed to have a present value at issuance measured by the cash proceeds
exchanged.” Paragraph 15 of APB Opinion No. 21 states that “the difference between the present
value and the face amount should be treated as a discount or premium and amortized as interest
expense or income over the life of the note in such a way as to result in a constant rate of interest
when applied to the amount outstanding at the beginning of any given period.” Persistency and
enhanced inducements are also analogous to non-level interest on fixed income securities.
AcSEC concluded that sales inducements should result in an effective yield being recognized
over the expected life of the contract, rather than expensing the persistency and enhanced
interest rate inducements as amounts are credited to the contract holder. This treatment will
result in capitalization of the sales inducement as it is accrued or credited to the account balance,
whichever is earlier.
Consideration of Sales Inducements as Deferred Acquisition Costs
A46.
AcSEC considered the arguments in favor of treating sales inducements as a deferred
acquisition cost. The insurance company prices the products based on total cash inflows and
outflows. Some argued that the form of the transaction that splits these outflows between agent
and the customer should be of no consequence, and the substance of the transaction is that
certain outflows are paid to induce the customer to acquire the product. AcSEC concluded that
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sales inducements do not meet the definition of a deferred acquisition cost because they are
benefits paid to contract holders, not payments to third parties.
Criteria for Capitalization
A47.
AcSEC considered the criteria for determining when a sales inducement is in excess of
normal crediting rates that would warrant capitalization. AcSEC believed it was necessary for an
insurance enterprise to explicitly demonstrate that such amounts are (a) incremental to amounts
the enterprise credits on similar contracts without sales inducements, and (b) higher than the
contract’s expected ongoing crediting rates for periods after the inducement; that is, the crediting
rate excluding the inducement should be consistent with assumptions used in estimated gross
profits, contract illustrations, and interest crediting strategies. These criteria are necessary to
prevent capitalization of interest crediting amounts that are current period benefit expenses.
Consideration of Expensing Sales Inducements in the Period Credited
A48.
AcSEC also considered the view that benefits payable to contract holders should be
charged to benefit expense in the period credited to the contract holder consistent with other
benefit payments. Under this method, AcSEC noted that sales inducements would be recorded as
a liability to the customer at the time they meet the definition of a liability, with an immediate
charge to expense as a benefit cost.
A49.
AcSEC recognized the long-duration nature of the contracts as defined in FASB
Statements No. 60 and 97 and was concerned that expensing sales inducements in the period
credited could lead to different accounting for contracts that are economically similar. AcSEC
noted that contract wording could easily be changed to obtain different accounting treatments.
For example, contracts with identical economic benefits to the contract holder could be designed,
one with an immediate bonus with a surrender charge expiring after five years and one with a
persistency bonus credited at the end of five years. Expensing sales inducements in the period
credited would result in very different accounting results even though the contracts were identical
economically and would result in loss at inception on the contract that offered an immediate sales
inducement. Another contract with a persistency bonus would give the contract holder the same
cash in the future and not have a loss at inception. Based on those concerns, AcSEC rejected the
concept of expensing sales inducements in the period credited and concluded to expense sales
inducements over the period that the long-duration contract is in force.
Amortization of Deferred Sales Inducements
A50.
For contracts accounted for under FASB Statement No. 97, the asset arising from sales
inducements should be amortized using methodology and assumptions consistent with those
used for deferred acquisition costs under FASB Statement No. 97, which is effectively the
expected life of the accumulation phase of the contract. Because FASB Statement No. 97
requires that the annuitization phase be viewed as a separate contract, the annuitization phase
should not be combined with the accumulation phase. Practice Bulletin 8, Application of FASB
Statement No. 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration
Contracts and for Realized Gains and Losses from the Sale of Investments, to Insurance
Enterprises, states “the amortization method described in FASB Statement No. 97 for universal
life-type contracts should be used for investment contracts that include significant surrender
charges or that yield significant revenue from sources other than the investment of contract
holders’ funds. This method matches amortization of deferred policy acquisition costs (DPAC)
with the recognition of gross profits. Otherwise, DPAC on investment contracts should be
amortized using an accounting method that recognizes acquisition and interest costs as expenses
at a constant rate applied to net policy liabilities and that is consistent with the interest method
under FASB Statement No. 91, Accounting for Nonrefundable Fees and Costs Associated With
Originating or Acquiring Loans and Initial Direct Costs of Leases (interest method).” This
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guidance is provided for the amortization of deferred acquisition costs, which in this context is
similar to debt issuance costs.
Effective Date and Transition
A51.
AcSEC concluded the SOP should be initially applied at the beginning of the fiscal year
that begins after December 15, 2003, which should permit companies sufficient time to implement
this SOP. AcSEC also concluded that it should allow companies the option of early adoption.
A52.
AcSEC concluded that the effect of initially adopting this SOP should be reported as a
cumulative effect of a change in accounting principle (in accordance with the provisions of APB
Opinion No. 20, Accounting Changes) and that restatement of prior annual financial statements
should be prohibited. AcSEC recognizes the benefits of comparable financial statements but
believes that due to significant judgment and the possible use of hindsight in applying the SOP,
and the significance of the efforts and costs likely to be incurred, retroactive restatement or pro
forma disclosures in the year of adoption should not be required.
A53.
AcSEC considered allowing entities the choice, for certain provisions of this SOP, to
reclassify previously reported financial statements as long as there was no valuation basis
adjustment affecting earnings while prohibiting reclassification when the valuation provisions of
this SOP would affect earnings. AcSEC concluded that the provisions of this SOP are not
fundamentally different from the FASB Statement No. 97 model and that allowing entities the
option of applying certain provisions while not others would result in inconsistent recognition of
liabilities, revenue, and acquisition costs. AcSEC concluded that allowing restatement in certain
circumstances while not allowing restatement in other circumstances is not appropriate.
Therefore, AcSEC decided not to permit restatement.
A54.
AcSEC concluded that securities subject to FASB Statement No. 115, Accounting for
Certain Investments in Debt and Equity Securities, previously carried at fair value that are
reclassified to the general account may be designated as held-to-maturity for debt securities,
available-for-sale for debt and equity securities, or trading for debt and equity securities. AcSEC
believed that previously the assets were being accounted for under separate account valuation
basis and, after reclassification to the general account, they are to be valued under general
account guidance. Accordingly, AcSEC concluded this designation is similar to an enterprise
initially adopting FASB Statement No. 115 for those securities. The guidance provided by AcSEC
is consistent with that provided in FASB Statement No. 115 for its initial adoption.
A55.
AcSEC also concluded that debt or equity securities subject to FASB Statement No. 115,
previously classified as part of a separate account but valued in accordance with paragraphs 45
through 51 of FASB Statement No. 60, as amended, should maintain the original designation as
held-to-maturity, available-for-sale, or trading. That designation previously was made in
accordance with FASB Statement No. 115 when the security was purchased and classified as a
separate account asset. Although under this SOP the securities are now classified as part of the
general account, the insurance enterprise has already assessed its intent under FASB Statement
No. 115, which is not changed.
A56.
Any revaluation adjustment for the securities described in paragraph A53 of this SOP
should be reported in a manner similar to the cumulative effect of a change in accounting
principle through net income or accumulated other comprehensive income, as appropriate. In its
deliberations, AcSEC considered both the transfer and transition guidance provided in FASB
Statement No. 115, paragraphs 15 and 25, related to reclassifications among categories. AcSEC
believes that the transition requirements of FASB Statement No. 115 are consistent with AcSEC’s
decision not to permit restatement resulting from adoption of this SOP.
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A57.
AcSEC concluded that, for debt or equity securities subject to FASB Statement No. 115
and classified as available-for-sale that are part of a contractually referenced pool of assets
where a total return will be accrued to the account balance liability, and a transition adjustment for
the liability valuation is reported in accordance with paragraph 37(e), the related debt or equity
securities may be reclassified to trading upon initial adoption of the SOP. In this case, AcSEC
believes the combined effect of the asset and liability transition adjustments should be reported in
a manner similar to the cumulative effect of a change in accounting principle. An enterprise may
not have designated a security as available-for-sale when it purchased the security if it had known
a contract holder liability designed to mimic the return would be recorded based on the
referenced asset in the statement of operations. In addition AcSEC noted that FASB Statement
No. 133 provides for similar transition treatment because the guidance for hedge accounting
significantly changed. AcSEC also made the analogy to the transition guidance in EITF Issue No.
97-14, Accounting for Deferred Compensation Arrangements Where Amounts Earned Are Held in
a Rabbi Trust and Invested.
A58.
The insurance enterprise’s accounting policies with regard to assets other than those
subject to FASB Statement No. 115 should be consistently applied upon reclassification of assets
from separate accounts to the general account at the date of initial adoption of the SOP. AcSEC
concluded that any revaluation adjustments related to assets other than those subject to FASB
Statement No. 115 should be reported in a manner similar to the cumulative effect of a change in
accounting principle.
A59.
AcSEC concluded that, because this SOP may change the way an insurance enterprise
applies the mortality and morbidity significance test and that the results of that test may change
the required liability valuation model, insurance enterprises should perform a new determination
of significance of mortality and morbidity risk resulting from the insurance benefit features of the
contract for purposes of contract classification at the date of initial adoption of this SOP. AcSEC
considered requiring this determination to be made as of original contract issuance, but rejected
that approach because it would not be practicable to obtain and document a range of reasonably
possible cash flow outcomes as of those inception dates without the inappropriate use of
hindsight. In addition to the burden of performing the test without original information, it would be
difficult to verify the appropriateness of the outcomes. AcSEC also considered requiring the
determination only for new contracts, but was concerned that would cause inconsistencies in the
accounting for similar contracts of an enterprise for many years due to the long-duration nature of
such contracts.
A60.
AcSEC considered whether to require restatement of contract holder liabilities as a result
of adoption of this SOP, but concluded that restatement is not necessary and may not be possible
to reconstruct. AcSEC concluded that any adjustment to contract holder liabilities from adoption of
this SOP should be reported in a manner similar to the cumulative effect of a change in
accounting principle in accordance with the provisions of APB Opinion No. 20, through net
income or, for amounts previously reported under EITF Topic No. D-41, accumulated other
comprehensive income.
A61.
AcSEC, in discussing sales inducements, recognized that some insurance enterprises
currently charge those costs to expense as incurred. AcSEC believes that the costs of developing
the information that would be necessary to determine the costs that would be capitalized if this
SOP were applied retroactively would exceed the benefits retroactive application might offer and
that such retroactive determination should not be made. AcSEC believes this treatment is
consistent with transition rules of other accounting guidance, such as SOP 98-1, Accounting for
the Costs of Computer Software Developed or Obtained for Internal Use.
A62.
AcSEC further concluded that the unamortized capitalized sales inducement balance at
transition should not be adjusted, but the balance would be subject to the amortization provisions
of this SOP on a prospective basis. Prospective treatment and prohibition on restating sales
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inducements capitalized is consistent with AcSEC’s conclusions on restatement of previously
expensed inducements. Identification and amortization of previously capitalized costs in
accordance with the provisions of this SOP should result in an acceptable level of comparability
and understandability.
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APPENDIX B
ILLUSTRATION FOR PRESENTATION OF AN INSURANCE ENTERPRISE’S
INTEREST IN A SEPARATE ACCOUNT
B1. The following example illustrates the presentation in the financial statements of an insurance
enterprise’s proportionate interest in separate accounts:
An insurance enterprise has a proportionate interest in XYZ separate account that represents
10 percent of the total separate account value. There are no subaccounts in the separate
account. The insurer’s interest of 10 percent is unchanged during the period.

The XYZ separate account assets are composed of the following:
Separate
Account at
Fair Value

Investment

Debt securities
Equity securities
Mortgage loans
Real estate
Total assets

400
300
250
130
$1,080

1

Separate
Account at
General
Account
Value1
400
300
200
100
$1,000

Insurer’s
Interest (%)

10%
10%
10%
10%
10%

Underlying investments valued in a manner similar to any other general account asset as prescribed in
Financial Accounting Standards Board (FASB) Statement of Financial Accounting Standards No. 60,
Accounting and Reporting by Insurance Enterprises, as amended, paragraphs 45 through 51.
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Proportionate
Interest

40
30
20
10
$100

Balances presented in the insurer’s statement of financial condition would reflect:
Assets:

Debt securities2
Equity securities2
Mortgage loans
Real estate
Total investments
Separate account – Assets3

Liabilities:

Separate account – Liabilities

40
30
20
10
100
$9724
$972

The applicable disclosures for the insurer’s proportionate interest in these specific assets
would be included within the applicable disclosures for the general account invested assets.
The XYZ separate account’s balances for net investment income and gains and losses are as
follows:

Net investment income (NII)
Realized gains and losses
Unrealized gains and losses:
Debt securities
Equity securities
Mortgage loans
Real estate
Total NII and gains and losses

2

XYZ
Separate
Account
Total
65
20
8
25
5
2
$125

Insurer’s
Interest (%)

Apportioned
Values

10%
10%
10%
10%
10%
10%

6.5
2.0
.8
2.5
.5
.2
12.5

Debt and equity securities need to be designated as either trading or available-for-sale.

3

If XYZ separate account held an investment in a mutual fund, a typical situation would be that the
insurance enterprise’s investment would have less than significant influence, and the interest would be
reported as a FASB Statement No. 115, Accounting for Certain Investments in Debt and Equity Securities,
equity security.
4

Separate account assets at fair value of $1,080 x 90% (contract holders’ proportionate interest).

5

Unrealized gain or loss to be included in revenue or other comprehensive income (OCI) depending on
security classification of trading or available-for-sale.

6

Unrealized gains are not recognized. Cumulative unrealized losses may result in recognition of an otherthan-temporary impairment.
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General
Account
Classification
Revenue
Revenue
5

Revenue or OCI
5
Revenue or OCI
6
Not recognized
6
Not recognized

APPENDIX C
SAMPLE DISCLOSURES
C1.
This appendix provides an illustration of the financial statement disclosure requirements
relating to paragraph 34 of this Statement of Position (SOP). Entities are not required to display
the disclosure information contained herein in the specific manner illustrated. Alternative ways of
disclosing the information are permissible as long as the disclosure requirements of this SOP, as
described in paragraph 34, are met.
The company issues variable contracts through its separate accounts for which investment
income and investment gains and losses accrue directly to, and investment risk is borne by,
the contract holder (“traditional variable annuities”). The company also issues variable annuity
and life contracts through separate accounts where the company contractually guarantees to
the contract holder (“variable contracts with guarantees”) either (a) return of no less than total
deposits made to the contract less any partial withdrawals, (b) total deposits made to the
contract less any partial withdrawals plus a minimum return, or (c) the highest contract value
on a specified anniversary date. These guarantees include benefits that are payable in the
event of death, annuitization, or during the accumulation period.
The assets supporting the variable portion of both traditional variable annuities and variable
contracts with guarantees are carried at fair value and reported as summary total separate
accounts assets with an equivalent summary total reported for liabilities. Amounts assessed
to the contract holders for mortality, administrative, and other services are included in
revenue and changes in liabilities for minimum guarantees are included in policyholder
benefits in the Statement of Operations. Deposits, net investment income, net investment
gains and losses, and the related liability changes are offset within the same line item in the
Statement of Operations.
The company provides to its variable account contract holders certain guarantees, which
include death benefit guarantees, guaranteed accumulation values, and guaranteed
annuitization values. Of the company’s separate account liabilities for variable contracts with
guarantees of $XXX, 80 percent have return of net deposits death benefit guarantees, while
20 percent have return of deposits at stated rates, which range from 4 to 6 percent. In
addition to death benefits, 10 percent guarantee accumulation benefits equal to deposits less
withdrawals for contracts held for 10 years, and 15 percent of the contracts guarantee a
minimum amount available to annuitize equal to deposits less withdrawals after specified
periods, which range from 10 to 15 years from issuance of the contract. As of December 31,
20XX, variable separate accounts with guarantees were invested as follows:

44

Asset Type
U.S. Treasury securities and obligations of
U.S. government corporations and
agencies
Obligations of states of the United States
and political subdivisions of the states

December 31, 20XX
$

Corporate debt securities:
- investment grade
- noninvestment grade
Foreign debt securities
Mortgage-backed securities
Equity securities
Real estate
Mortgage loans
Derivative financial instruments
Cash and cash equivalents
Total variable separate account assets
with guarantees

$

X,XXX,XXX

Liabilities of $XXX are established for contracts containing death benefit guarantees.
Annuitization guarantees are recognized over the annuitization period if and when the
contract holder elects to annuitize. Guaranteed accumulation benefits are considered to be
derivatives under Financial Accounting Standards Board (FASB) Statement of Financial
Accounting Standards No. 133, Accounting for Derivative Instruments and Hedging Activities,
and are recognized at fair value through earnings. The following summarizes the liabilities for
guarantees on variable contracts reflected in the general account:

Balance at January 1

Guaranteed Minimum
Death Benefit
$
X,XXX,XXX

Guaranteed
Accumulation Benefit
$
X,XXX,XXX

$

X,XXX,XXX

$

X,XXX,XXX

$

X,XXX,XXX

$

X,XXX,XXX

Incurred guarantee benefits*
Paid guarantee benefits
Balance at December 31
Incurred guarantee benefits
Paid guarantee benefits
Balance at December 31

* For guaranteed accumulation benefits, incurred guarantee benefits would incorporate all changes in fair
value other than amounts resulting from paid guarantee benefits.
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APPENDIX D
APPLICATION OF STATEMENT OF POSITION—PRODUCT AND PRODUCT
FEATURE EXAMPLES

Market Value Annuity
D1. A market value annuity (MVA) provides for a return of principal plus a fixed rate of return if
held to maturity (referred to herein as book value), or, alternatively, a "market adjusted value" if
surrendered prior to maturity. The product is also sometimes referred to as a "market value
adjusted annuity" or "modified guaranteed annuity." The product typically provides for a single
premium that may be invested for a specified term, with typical terms of one to ten years. A fixed
interest rate is specified in the contract based upon the term selected. The contract contains
surrender values that are based upon a market value adjustment formula if held for shorter
periods. The formula typically is based on current crediting rates being offered for new MVA
purchases with terms equal to the remaining term to maturity. The market value adjustment may
be positive or negative, depending upon crediting rates at surrender.
D2. Because the insurance enterprise provides a fixed return for a specified period, market value
adjusted annuities written through a separate account do not meet the criteria in paragraph 10(d)
of this Statement of Position (SOP). Under paragraph 10(d) of this SOP, all investment
performance, net of contract fees, must be required to be passed through to the contract holder to
qualify for separate account treatment. Therefore, the assets and liabilities related to market
value adjusted annuities should be accounted for and reported as general account assets and
liabilities.
D3. Under the model, described in paragraphs 17 through 21 of this SOP, the liability to be held
for market value adjusted annuities is the accrued account balance using the contractually
specified rate. The market value adjusted amount generally is available at surrender only and is
not available at contract maturity; therefore, the market value adjustment is considered a
surrender charge or credit.
Two-Tier Annuities
D4. A two-tier annuity has two crediting rates applied to funds deposited into the contract. One
rate is used to calculate the account balance if the contract holder elects to surrender the contract
for cash, and is referred to as the “lower tier”. A second rate, typically higher, is used to calculate
the account balance but only if the contract holder elects to annuitize the contract, and is referred
to as the “upper tier”.
D5. This SOP requires that the contract holder liability during the accumulation phase be
calculated using the lower tier rate because the account balance accumulated at the lower tier is
the amount that would be available in cash at maturity if the contract holder elects not to annuitize
the contract. Under the guidance in this SOP, when a contract holder elects to annuitize, the
lower tier contract holder liability is treated as the single premium used to “purchase” the
annuitization benefit. Similar to other single premium investment contracts, an implicit interest rate
based on this single premium and the expected future cash flows would be used to accrue future
contract holder liabilities. For payout annuities with other than nominal mortality and morbidity risk
the guidance in Financial Accounting Standards Board (FASB) Statement of Financial Accounting
Standards No. 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration
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Contracts and for Realized Gains and Losses from the Sale of Investments, related to limitedpayment contracts should be followed.
D6. No additional liability should be recognized during the accumulation phase for the upper tier
account balance, as the annuitization benefit is an elective benefit and is accounted for during the
annuitization phase of the contract. AcSEC did not consider an account balance based on the
upper tier to be a balance available in cash or its equivalent.
Variable Annuity With Guaranteed Minimum Accumulation Benefit
D7. Some deferred annuities provide a minimum accumulation benefit or a guaranteed account
value floor that is available to the contract holder in cash. These benefits are often referred to as
guaranteed minimum accumulation benefits, or “GMABs.”
D8. Example: Contract holder deposits $100,000 in a deferred variable annuity that provides for a
GMAB that guarantees that at a specified anniversary date (for example, five years), the contract
holder’s account balance will be the greater of (a) the account value, as determined by the
separate account assets, or (b) deposits less partial withdrawals accumulated at 3 percent
interest compounded annually. At the specified anniversary date the contract holder’s account
balance has declined to $80,000 due to stock market declines. The guaranteed minimum value of
the $100,000 deposit compounded annually at 3 percent interest is $115,930. The contract
holder’s account balance will be increased to the greater amount, resulting in an account balance
of $115,930. FASB Derivative Implementation Issue B8, Identification of the Host Contract in a
Nontraditional Variable Annuity Contract, specifies that a GMAB is an embedded derivative
subject to the requirements of FASB Statement No. 133, Accounting for Derivative Instruments
and Hedging Activities. The remaining part of the hybrid contract should be accounted for
separately.
Variable Annuity With Guaranteed Minimum Income Benefit
D9. Some deferred variable annuities guarantee that, regardless of separate account investment
performance, the contract holder will be able to annuitize after a specified date and receive a
defined minimum periodic benefit. These benefits are available only if the contract holder elects to
annuitize and are often referred to as guaranteed minimum income benefits, or “GMIBs.”
D10. Example: A contract holder deposits $100,000 in a deferred variable annuity that provides
a GMIB. The GMIB specifies that if the contract holder elects to annuitize, the amount available to
annuitize will be the higher of the then account balance or the sum of deposits less withdrawals.
The contract holder directs the deposit to equity-based funds within the separate account. At the
date that the contract holder chooses to annuitize, the account balance has declined to $80,000
due to stock market declines. The contract holder elects a 20-year period-certain fixed payout
annuity, payable monthly in arrears. Using the $100,000 guaranteed minimum account value at
the date of annuitization and a guaranteed 3 percent crediting rate, the fixed monthly periodic
annuity payment is $554.
D11. Under the accretion model, during the accumulation phase, the liability to be held for a
variable annuity with a GMIB that does not meet the net settlement criteria of FASB Statement
No. 133, would be the accrued account balance. No additional liability should be held for the
annuitization option, as the annuitization benefit is an elective benefit and is accounted for during
the annuitization phase of the contract. FASB Derivative Implementation Issue B25, Deferred
Variable Annuity Contracts with Payment Alternatives at the End of the Accumulation Period,
specifies that a GMIB does not meet the definition of an embedded derivative if it cannot be net
settled. If the GMIB can be net settled, the guarantee is an embedded derivative in the
accumulation period and should be accounted for under FASB Statement No. 133.
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Variable Annuity and Life Insurance
D12. Variable annuity and variable life insurance contracts provide the contract holder with a
number of investment alternatives. Many of those investment alternatives will be separate
account funds, such as equity, aggressive equity, high-grade corporate bond, mortgage loan, real
estate and similar funds, that satisfy the criteria contained in paragraph 10 of this SOP. Other
investment alternatives could include guaranteed investment and market value adjusted separate
accounts as well as a general account fixed interest rate option.
D13. Example: Contract holder deposits $100,000 in a deferred variable annuity that has no
front-end load. The contract holder directs the allocation of the deposit to: aggressive growth
equity fund $25,000; high-yield corporate bond fund $25,000; five-year guaranteed interest
separate account $25,000; and general account $25,000.
D14. Assets representing the contract holder’s funds in the aggressive growth equity fund and
high-yield corporate bond fund separate accounts satisfy all the criteria of paragraph 10 of this
SOP. The allocation to the guaranteed interest separate account does not satisfy the criterion of
paragraph 10(d) of this SOP. Therefore, assets representing the contract holder’s funds in the
guaranteed interest separate account will be presented in the insurance enterprise’s financial
statements integrated with general account assets and liabilities. This reporting is appropriate
even in those instances where the separate account arrangements with those contracts have
been approved by regulatory authorities as separate account contracts. These contracts are often
referred to as spread products, where the insurer bears the investment risk and its profits are
derived primarily from the excess of investment performance over net amounts credited to the
contract holder. Amounts related to this contract that are directed to the general account option
will, of course, be shown within general account balances.
Group Participating Pension Contracts
D15. Some FASB Statement No. 97 contracts between insurance enterprises and pension
plans have account balance crediting provisions that give the contract holder the total return
based on a referenced pool of assets over the life of the contract either through crediting rates or
termination adjustments. The ongoing crediting to the account balance may be based on
statutory, cash basis, or book value returns. The contracts may not have a maturity date but
specify that upon surrender any remaining return on the referenced pool of assets on the
termination date not yet credited will be a termination adjustment. The referenced pool of assets
may include mortgage loans, real estate, equity and debt securities.
D16. This SOP requires that, for contracts not accounted for under the provisions of FASB
Statement No. 133, the liability for the contract holder account balance be based on the fair value
of the referenced pool of assets without regard to the accounting under GAAP for the assets in
the referenced pool of assets, with any change in the liability recognized through earnings.
Sales Inducements to Contract Holders
D17. Sales inducements to contract holders typically can be characterized as one of the
following types: immediate bonuses, persistency bonuses, and enhanced crediting rate bonuses.
D18. In the case of the immediate bonus, the insurance company is obligated to credit to the
contract holder’s account the sales inducement as a result of signing the contract. The contract
holder account balance is increased for the full amount of the immediate bonus on the date that
the bonus is contractually granted. If the criteria in paragraph 33 of this SOP are met, an asset
should be established for the same amount. Even if a company were to impose a prepayment
penalty designed to recover the sales inducement, paragraph 18 of FASB Statement No. 97
specifies that amounts assessed against policyholders in future periods cannot be considered in
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determining the liability for policy benefits. The prepayment penalty for the sales inducement
would be treated no differently than any other surrender charge.
D19. A persistency bonus is credited to the contract holder account balance at the end of a
specified period if the contract remains in force at that date. The amount that will be credited in
accordance with the terms of the contract should be accrued as a component of the contract
holder account balance ratably over the vesting period. If the criteria in paragraph 33 of this SOP
are met, an asset should be established. While it may not become payable by the insurance
company until some future vesting or crediting date, the insurance enterprise is prohibited by
FASB Statement No. 97 from anticipating surrenders and must assume the contract holder will
persist to earn the bonus.
D20. In an enhanced crediting rate sales inducement the insurance enterprise offers
customers a crediting rate for a stated period in excess of that currently being offered by the
company for other similar contracts. Pursuant to the contract, the enhanced crediting rate is
applicable for a limited period of time, after which, the rate is “reset” under the contractual
provisions, typically at the discretion of the insurance enterprise. The liability for an enhanced
crediting rate sales inducement should be accrued ratably over the bonus crediting period. If the
criteria in paragraph 33 of this SOP are met, an asset should be established for the same
amount.
Variable Annuity With Long-Term Care Benefit
D21. Some deferred annuities provide that if during the accumulation phase, the contract
holder has an insurable event (for example, disability, loss of “activities of daily living”) that meets
the criteria specified in the contract, additional benefits in excess of the account balance will be
available. This feature should be evaluated and accounted for in accordance with paragraphs 23
through 30 of this SOP.
Annuities With Earnings Protection Benefit
D22. Some annuities provide that in the event of death the beneficiary will receive a benefit in
addition to the account balance equal to a percentage (for example, 40 percent) of the difference
between the account balance and the deposits less withdrawals. This feature is a death benefit
and should be evaluated and accounted for in accordance with paragraphs 23 through 30 of this
SOP.
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APPENDIX E
ILLUSTRATIONS OF THE CALCULATION OF MINIMUM GUARANTEED DEATH
BENEFIT LIABILITY

E1. The accompanying schedules illustrate how to calculate an additional liability for a portfolio of
variable annuity contracts with a minimum guaranteed death benefit (MGDB) feature as noted in
paragraphs 26 through 29 of this Statement of Position (SOP). For this illustration it is assumed
that the guidance in paragraphs 23 through 25 of this SOP has been followed, with the conclusion
that the mortality and morbidity risk associated with insurance benefit features is other than
nominal.
E2.
(a)
(b)
(c)

The following is assumed:
Variable annuity contracts with no front-end loads
Mortality assessments include any explicit assessments for enhanced death benefit feature
Discount rate of 8 percent is the same rate as used for deferred acquisition cost amortization.

E3. Schedules 6 through 10 contain the same basic assumptions as Schedule 1, but with the
impact on the adjusted gross profits of a 10 percent increase in account balances (not shown in
schedules) in year 2.
E4.
(a)
(b)
(c)
(d)

The illustrations display the computations involved in:
Gross profits
Benefit ratio
Additional MGDB liability
Adjusted gross profits that should be used for the amortization of deferred acquisition costs1
Note: Columns in schedules do not cross foot due to rounding.

1

The estimated gross profits used for the amortization of deferred acquisition costs should be adjusted to
reflect the incidence of assessments and loss expense as a result of the recognition of the liability, refer to
paragraph 29 of this Statement of Position.
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Schedule 1—Example of Unadjusted Gross Profits Calculation
Recurring
Expense +

Mortality

+

=

Total

1

Expenses

-

Benefits

Unadjusted
=

Gross

Year

Assessments

1

30.00

820.50

17.50

868.00

25.00

0.00

843.00

2

29.75

871.65

44.62

946.02

170.27

12.20

763.55

3

29.48

919.29

61.42

1,010.20

177.78

20.61

811.80

4

29.20

969.80

68.12

1,067.12

185.96

25.94

855.22

5

28.89

1,034.77

64.99

1,128.65

196.53

31.58

900.54

6

28.55

1,086.61

95.16

1,210.32

204.89

44.05

961.38

7

28.18

1,143.53

58.71

1,230.42

214.07

49.53

966.82

8

27.78

1,086.61

0.00

1,114.39

224.32

52.00

838.07

9

27.34

1,268.91

0.00

1,296.25

234.27

65.93

996.05

10

26.87

1,333.10

0.00

1,359.97

244.57

76.78

1,038.61

11

26.35

1,382.93

0.00

1,409.28

252.45

93.75

1,063.08

12

25.79

1,433.09

0.00

1,458.87

243.67

104.76

1,110.44

Assessments

Charges

Revenue

Incurred

Paid

Profits

13

25.18

1,487.10

0.00

1,512.27

268.83

120.67

1,122.78

14

24.52

1,539.66

0.00

1,564.18

278.10

142.22

1,143.86

15

23.81

1,597.88

0.00

1,621.69

286.16

151.25

1,184.28

16

23.06

1,662.23

0.00

1,685.28

296.25

153.64

1,235.39

17

22.25

1,691.70

0.00

1,713.95

300.49

210.92

1,202.54

18

21.39

1,723.70

0.00

1,745.09

305.11

236.72

1,203.27

19

20.48

1,751.22

0.00

1,771.70

308.93

270.72

1,192.05

20

19.52

1,788.11

0.00

1,807.63

314.28

270.82

1,222.52

724.88

9,520.96

PV
1

Surrender

Excess Death

12,304.07

If the product had investment margins they would be included in the example as an additional column.
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Schedule 2—Computation of Benefit Ratio

Present value of excess death benefits paid
Divided by present value of total revenue

724.88
12,304.07

Equals benefit Rratio

5.8914%

Schedule 3—Computation of Year 1 Additional MGDB Liability

Cumulative revenue recognized
Multiplied by benefit ratio

868.00
5.8914%

Equals year 1 additional liability

($)
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Schedule 4—Additional MGDB Liability
Amortized Over Total Revenue
Beginning

Total Revenue

Additional MGDB

Year

Liability

+

Ending

x

Interest

+

1

0.00

0.00

Benefit
Factor
51.14

2

51.14

4.09

3

98.76

4

-

Excess
Death
Benefits
Paid

=

Additional MGDB

Change in
Additional

Liability

Liability

0.00

51.14

51.14

55.73

12.20

98.76

47.63

7.90

59.51

20.61

145.57

46.81

145.57

11.65

62.87

25.94

194.15

48.57

5

194.15

15.53

66.49

31.58

244.59

50.45

6

244.59

19.57

71.30

44.05

291.41

46.82

7

291.41

23.31

72.49

49.53

337.69

46.28

8

337.69

27.02

65.65

52.00

378.35

40.66

9

378.35

30.27

76.37

65.93

419.06

40.70

10

419.06

33.52

80.12

76.78

455.92

36.86

11

455.92

36.47

83.03

93.75

481.67

25.75

12

481.67

38.53

85.95

104.76

501.39

19.72

13

501.39

40.11

89.09

120.67

509.93

8.54

14

509.93

40.79

92.15

142.22

500.65

-9.27

15

500.65

40.05

95.54

151.25

484.99

-15.66

16

484.99

38.80

99.29

153.64

469.44

-15.55

17

469.44

37.56

100.98

210.92

397.05

-72.39

18

397.05

31.76

102.81

236.72

294.91

-102.14

19

294.91

23.59

104.38

270.72

152.16

-142.75

20

152.16

12.17

106.49

270.82

0.00

-152.16
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Schedule 5—Estimated Gross Profits to Use for Amortization of Deferred Acquisition Costs
Unadjusted
Gross Profits

-

Change in
Additional
Liability

=

Estimated
Gross
Profits

Year
1
2
3
4
5
6
7
8
9
10

843.00
763.55
811.80
855.22
900.54
961.38
966.82
838.07
996.05
1,038.61

51.14
47.63
46.81
48.57
50.45
46.82
46.28
40.66
40.70
36.86

791.86
715.92
765.00
806.64
850.09
914.56
920.55
797.40
955.35
1,001.75

11
12
13
14
15
16
17
18
19
20

1,063.08
1,110.44
1,122.78
1,143.86
1,184.28
1,235.39
1,202.54
1,203.27
1,192.05
1,222.52

25.75
19.72
8.54
-9.27
-15.66
-15.55
-72.39
-102.14
-142.75
-152.16

1,037.34
1,090.72
1,114.24
1,153.13
1,199.94
1,250.95
1,274.93
1,305.41
1,334.80
1,374.68
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Schedule 6—Example of Unadjusted Gross Profits Calculation With 10 Percent Increase in Account Balances in Year 2
Recurring
+

Surrender

Total

-

Mortality

Year

Assessments

Assessments

1

30.00

820.50

17.50

868.00

25.00

0.00

843.00

2

29.75

952.20

44.62

1,026.58

183.70

0.00

842.88

3

29.48

1,004.82

61.42

1,095.72

192.04

14.70

888.98

4

29.20

1,060.59

68.12

1,157.91

201.10

23.32

933.50

Revenue

Expenses
Incurred

-

Benefits

Unadjusted

Expense +

Charges

=

Excess Death
=

Paid

Gross
Profits

5

28.89

1,131.90

64.99

1,225.78

212.72

30.43

982.63

6

28.55

1,189.01

95.16

1,312.72

221.96

44.65

1,046.10

7

28.18

1,251.32

58.71

1,338.21

232.04

51.02

1,055.15

8

27.78

1,189.01

0.00

1,216.79

243.33

54.23

919.23

9

27.34

1,389.04

0.00

1,416.38

254.29

68.42

1,093.67

10

26.87

1,456.89

0.00

1,483.76

265.21

82.24

1,136.32

11

26.35

1,511.61

0.00

1,537.96

273.89

101.42

1,162.64

12

25.79

1,568.05

0.00

1,593.83

264.30

112.70

1,216.83

13

25.18

1,626.63

0.00

1,651.81

292.09

131.08

1,228.64

14

24.52

1,683.48

0.00

1,708.00

302.07

154.93

1,251.00

15

23.81

1,747.40

0.00

1,771.22

311.08

163.02

1,297.12

16

23.06

1,814.73

0.00

1,837.79

321.67

167.79

1,348.33

17

22.25

1,845.71

0.00

1,867.96

326.16

232.38

1,309.42

18

21.39

1,878.58

0.00

1,899.97

330.92

261.62

1,307.43

19

20.48

1,909.07

0.00

1,929.54

335.24

296.86

1,297.44

20

19.52

1,950.07

0.00

1,969.58

341.27

296.31

1,332.00

759.24

10,338.27

13,326.45

Present
value
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Schedule 7—Computation of Benefit Ratio at Year 2

Present value of excess death benefits paid
Divided by present value of total revenue

=

Equals benefit ratio

759.24
13,326.45
5.6972%

Schedule 8—Computation of Year 2 Additional MGDB Liability

Cumulative revenue recognized
Year 1
Year 2
Total

868.00
1026.58
1,894.58

Multiplied by benefit ratio

5.6972%

Equals year 2 additional liability1

1

($)

107.94

Excludes interest and any deduction for actual claim expenses.
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Schedule 9—Additional MGDB Liability
Amortized Over Total Revenue
Beginning

Total Revenue

Additional MGDB
Year

1

1
2

Liability

0.00

+

Ending

x
Interest

0.00

+

Benefit
Factor

-

49.45

1
1

Excess
Death
Benefits
Paid

=

Additional
MGDB
Liability

Change in
Additional
Liability

0.00

49.45 2

51.14

0.00

111.89

3

60.75

2

49.45

3.96

58.49

3

111.89

8.95

62.43

14.70

168.57

56.68

4

168.57

13.49

65.97

23.32

224.71

56.14

5

224.71

17.98

69.84

30.43

282.09

57.38

6

282.09

22.57

74.79

44.65

334.79

52.70

7

334.79

26.78

76.24

51.02

386.80

52.01

8

386.80

30.94

69.32

54.23

432.84

46.04

9

432.84

34.63

80.69

68.42

479.74

46.90

10

479.74

38.38

84.53

82.24

520.41

40.67

11

520.41

41.63

87.62

101.42

548.24

27.83

12

548.24

43.86

90.80

112.70

570.21

21.97

13

570.21

45.62

94.11

131.08

578.86

8.65

14

578.86

46.31

97.31

154.93

567.55

-11.31

15

567.55

45.40

100.91

163.02

550.84

-16.71

Year 1, 49.45 + year 2, 58.49 = 107.94, as noted in Schedule 8, plus interest of 3.96 = 111.89.
This represents the recomputed end-of-year liability using the new expense in year 2.

3

The difference between the actual year 1 liability (51.14 as seen in Schedule 4) and the recomputed amount of (49.45) of 1.69 will be the true-up adjustment
included in the year 2 statement of operations (111.89 – 49.45 –1.69 = 60.75).
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16

550.84

44.07

104.70

167.79

531.82

-19.02

17

531.82

42.55

106.42

232.38

448.41

-83.41

18

448.41

35.87

108.25

261.62

330.91

-117.50

19

330.91

26.47

109.93

296.86

170.46

-160.45

20

170.46

13.64

112.21

296.31

0.00

-170.46
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Schedule 10—Estimated Gross Profits to Use for Amortization of Deferred Acquisition Costs
Unadjusted
Gross Profits

-

Change in
Additional
Liability

=

Estimated
Gross
Profits

Year
1
2
3
4
5
6
7
8
9
10

843.00
842.88
888.98
933.50
982.63
1,046.10
1,055.15
919.23
1,093.67
1,136.32

51.14
60.75
56.68
56.14
57.38
52.70
52.01
46.04
46.90
40.67

791.86
782.13
832.30
877.36
925.25
993.40
1003.14
873.19
1046.77
1095.65

11
12
13
14
15
16
17
18
19
20

1,162.64
1,216.83
1,228.64
1,251.00
1,297.12
1,348.33
1,309.42
1,307.43
1,297.44
1,332.00

27.83
21.97
8.65
-11.31
-16.71
-19.02
-83.41
-117.50
-160.45
-170.46

1134.81
1194.86
1219.99
1262.31
1313.83
1367.35
1392.83
1424.93
1457.89
1502.46
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GLOSSARY

accumulation phase. The period during an annuity contract prior to annuitization. An insurance
enterprise may refer to this type of annuity as a deferred annuity.
annuitization phase. The period during which the contract holder is receiving periodic payments
from an annuity, also referred to as the payout phase.
general account. All operations of an insurance enterprise that are not reported in the separate
account(s).
guaranteed investment option. Component of a variable contract that guarantees a specific
rate of performance.
guaranteed minimum income benefit (GMIB). Benefit normally offered with deferred variable
annuities to provide a guaranteed minimum amount that can be annuitized after a specified
period.
long-term care (LTC) benefit. Benefit offered in an annuity product with a rider providing
amounts in excess of the account balance to provide for LTC benefits if contract holder meets the
criteria for restrictions on activities of daily living.
minimum guaranteed death benefit (MGDB). A feature in an annuity, life insurance, or similar
contract that provides that in the event of an insured’s death, the beneficiary (or insurer in the
case of a reinsurance contract) will receive the higher of the current account balance of the
contract or another amount defined in the contract.
sales inducements. Sales inducements are product features that enhance the investment yield
to the contract holder on the contract. The three main types of sales inducements are: (1) day
one bonus, which increases the account value at inception, also called immediate bonus, (2)
persistency bonus, which increases the account value at the end of a specified period, and (3)
enhanced yield, which credits interest for a specified period in excess of rates currently being
offered for other similar contracts. Bonuses can be defined as contractually obligated
inducements that are explicitly identified in the contract and are in excess of current market
conditions.
seed money. An investment of non-contract holder funds by an insurer in a separate account
when it is established, to support the initial or on-going operations of the separate account.
separate account. A separate investment account established and maintained by an insurance
enterprise under relevant state insurance law to which funds have been allocated for certain
contracts of the insurance enterprise or similar accounts used for foreign originated products.
separate account arrangement. An arrangement under which all or a portion of a contract
holder’s funds is allocated to a specific separate account maintained by the insurance enterprise.
Examples include a variable life insurance contract offered through an insurance enterprise’s high
return separate account and a contract holder’s allocation of a portion of his or her deposit in a
deferred variable annuity to a growth equity fund.
traditional variable annuity. An insurance product in which all the contract holder’s payments
are used to purchase units of a separate account. The contract holder directs the allocation of the
account value among various investment alternatives and bears the investment risk. The units
may be surrendered for their current value in cash (usually less a surrender change) or applied to
60

purchase annuity income. The insurance enterprise periodically deducts mortality and expense
charges from the account.
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